var data={"specialtyName":"Authors and Editors in Dermatology","contributorTypes":

[{"name":"Editors-in-Chief","contributors":[{"name":"Jeffrey Callen, MD, FACP,

FAAD","credentials":["Editor-in-Chief — Dermatology\n","Section Editor — Skin and
Systemic Disease\n","Professor of Medicine\n","University of Louisville School of
Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in
patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and
Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus
erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations
for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson
and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS; Walgreens
[Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab,
tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen; Celgene;
Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and
Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions (Thalidomide,
apremilast, etanercept, adalimumab, tofacitinib)]."}]},{"name":"Deputy
Editors","contributors":[{"name":"Rosamaria Corona, MD, DSc","credentials":["Deputy
Editor — Dermatology"],"disclosure":""},{"name":"Abena O Ofori, MD","credentials":
["Deputy Editor — Dermatology\n","Assistant Professor of Medicine, Dermatology
Division\n","Medical College of Georgia"],"disclosure":""}]},{"name":"Section
Editors","contributors":[{"name":"Jeffrey Callen, MD, FACP, FAAD","credentials":
["Editor-in-Chief — Dermatology\n","Section Editor — Skin and Systemic
Disease\n","Professor of Medicine\n","University of Louisville School of
Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in
patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and
Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus
erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations
for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson
and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS; Walgreens
[Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab,
tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen; Celgene;
Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and
Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions (Thalidomide,
apremilast, etanercept, adalimumab, tofacitinib)]."},{"name":"Kristina Callis
Duffin, MD","credentials":["Section Editor — Psoriasis\n","Associate Professor,
Department of Dermatology\n","University of
Utah"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Psoriasis
(Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene
Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab
and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company
[Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen
Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)];
Stiefel Laboratories [Psoriasis (Calcipotriene)]. Consultant/Advisory Boards: Amgen
[Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)];
Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis
(Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers
Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)];
Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and
infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]."},{"name":"Mark V
Dahl, MD","credentials":["Section Editor — Acne and Rosacea\n","Professor
Emeritus\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Robert P
Dellavalle, MD, PhD, MSPH","credentials":["Section Editor — General
Dermatology\n","Professor of Dermatology and Public Health\n","University of
Colorado School of Medicine\n","Colorado School of Public Health\n","Chief,
Dermatology Service\n","US Department of Veterans Affairs\n","Eastern Colorado
Health Care System"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer
Pharmaceuticals [Independent research grant to the University of Colorado
(Development of patient decision aids)]. Other Financial Interest: Editorial
stipends from the Journal of Investigative Dermatology and the Journal of the
American Academy of Dermatology."},{"name":"Jeffrey S Dover, MD,
FRCPC","credentials":["Section Editor — Cosmetic Dermatology\n","Associate Clinical
Professor of Dermatology\n","Yale University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan; Evolus;
Valeant Pharmaceuticals [Neuromodulators, fillers]; Cutera; Cynosure; Lumenis;
Syneron; Valeant Pharmaceuticals [Lasers, lights]; Merz [Toxin, filler]; Shaser
Bioscience [Intense pulse light hair removal (Hair removal device)]; Zeltiq
Aesthetics [Body contouring (Fat loss system)]; Revance [Neuromodulator]; Sienna
[Lasers]. Consultant/Advisory Boards: Maison de Beaute; Web MD; Sky Biodevices;
Syneron; Shaser Bioscience; Cutera; Cynosure; Lumenis; Valeant Pharmaceuticals
[Lasers, lights]; Kythera Biopharmaceuticals [Fat saponification]; Myoscience
[Neuromuscular]; Topokine Therapeutics [Fat modulation (Biologics)]; Zeltiq
Aesthetics [Body contouring (Fat loss system)]; Valeant Pharmaceuticals [Fillers,
toxin]; Sienna [Lasers]. Equity Ownership/Stock Options: CVS/Skin Effects [Skin
care]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)];
Sky Biodevices [Skin cancer screening]. Other Financial Interest: Cynosure;
Lumenis; Syneron [Use of equipment (Lasers, lights)]."},{"name":"Craig A Elmets,
MD","credentials":["Section Editor — Photodermatology\n","Professor and Chair of
Dermatology\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Solgenix [CTCL
(SGX301)]; Kyowa Hakko USA [CTCL (Mogamulizumab)]; CA Assn of Wine Growers
[Photoprotection (Grapes)]; Ferndale Labs [Photoprotection (Polypodium
leukotomos)]; Elorac [CTCL (Topical Naloxone]); Idera [Dermatomyositis (IMO-8400)].
Consultant/Advisory Boards: Ferndale Labs [Photoprotection (Polypodium
leukotomos)]; Astellas Pharma US [Data Safety Monitoring Board - Atopic Dermatitis
(Tacrolimus)]. Equity Ownership/Stock Options: Aevi Genomic Medicine (Gene
therapy); Vaxin (Topical vaccines)."},{"name":"Joseph Fowler, MD","credentials":
["Section Editor — Dermatitis\n","Clinical Professor of Dermatology\n","University
of Louisville School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Galderma, Merck; Pfizer; Novartis; Lilly; Regeneron [Acne, Eczema,
psoriasis (Trifarotene, Crisaborole, MK3223, tofacitinib, secukinumab, ixekizumab,
dupilumab)]. Speaker's Bureau: SmartPractice [Eczema (Crisaborole, epicutaneous
patch test)]. Consultant/Advisory Boards: Intraderm [Eczema (Hypochlorous
acid)]."},{"name":"Jennifer L Hand, MD","credentials":["Section Editor —
Genodermatoses\n","Associate Professor of Dermatology, Medical Genetics, and
Pediatrics\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Maria
Hordinsky, MD","credentials":["Section Editor — Hair and Scalp Disease\n","Chair
and Professor - Department of Dermatology\n","University of Minnesota Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte Corporation
[Alopecia areata (Topical Janus kinase inhibitor)]; Allergan [Male pattern baldness
(Setipiprant tablets)]; Pfizer [Alopecia areata (Oral Janus kinase inhibitor)].
Consultant/Advisory Boards: Concert Pharmaceuticals [Alopecia areata (Oral Janus
kinase inhibitor)]; BiologicsMD [Alopecia, androgenetic alopecia (Hair cycle
stimulator, subcutaneous injection)]; Bionz [Alopecia areata]. Other financial
interest: Pantene Institute/Proctor & Gamble (Hair care products)."},{"name":"Moise
L Levy, MD","credentials":["Section Editor — Pediatric Dermatology\n","Professor of
Pediatrics and Medicine (Dermatology)\n","Dell Medical School, University of Texas,
Austin\n","Clinical Professor of Dermatology and Pediatrics\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Anacor
Pharmaceuticals [Atopic dermatitis (Investigational drug)]; Scioderm [Epidermolysis
bullosa (Topical treatment investigation)]. Speaker's Bureau: Anacor
Pharmaceuticals [Atopic dermatitis (Investigational drug)]. Consultant/Advisory
Boards: Castle Creek Pharmaceuticals [Epidermolysis bullosa (New drug in
development)]. Patent Holder: Incontinentia pigmenti (NEMO gene mutations)."},
{"name":"Stanley J Miller, MD","credentials":["Section Editor — Dermatologic
Surgery\n","Associate Professor of Dermatology and Otolaryngology/Head and Neck
Surgery, Part-Time\n","Johns Hopkins Hospital"],"disclosure":""},{"name":"Maja
Mockenhaupt, MD, PhD","credentials":["Section Editor — Drug Eruptions\n","Professor
of Dermatology\n","Medical Center - University of Freiburg,
Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Tibotec; Janssen;
Gruenenthal; GlaxoSmithKline; Sanofi-Aventis; AB-Science; Boehringer Ingelheim;
UCB-Biopharma [Severe cutaneous adverse reactions (Epidemiologic studies of severe
cutaneous adverse reactions)]. Consultant/Advisory Boards: Merck; Pfizer [Severe
cutaneous adverse reactions]."},{"name":"June K Robinson, MD","credentials":
["Section Editor — Nonmelanoma Skin Cancer\n","Professor of Clinical
Dermatology\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Ted Rosen, MD","credentials":["Section Editor
— Infections and Infestations\n","Professor, Department of Dermatology\n","Baylor
College of Medicine"],"disclosure":"Consultant/Advisory Boards: Cipher [Herpes
labialis (Acyclovir
buccal tablet)]; Medimetriks [Impetigo (Ozenoxacin topical)]."},{"name":"Jean-
Claude Roujeau, MD","credentials":["Section Editor — Drug Eruptions\n","Emeritus
Professor of Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil,
France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis
(Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in
development)]."},{"name":"Robert S Stern, MD","credentials":["Section Editor —
Nonmelanoma Skin Cancer\n","Professor of Dermatology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Advance
skin cancer (Checkpoint inhibitors)]; Plexxikon [Advance skin cancer (Various
drugs)]; Hydra [Advance skin cancer (Various drugs)]. Other Financial Interest:
Mylan [Skin reactions (Expert in product liability case concerning phenytoin skin
reaction)]; United State Department of Justice [Malpractice defense]."},
{"name":"Erik Stratman, MD","credentials":["Section Editor — Dermatologic
Diagnosis\n","Clinical Professor of Dermatology\n","University of Wisconsin
Madison"],"disclosure":""},{"name":"Hensin Tsao, MD, PhD","credentials":["Section
Editor — Melanocytic Lesions and Disorders of Pigmentation\n","Professor of
Dermatology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Epiphany Dermatology [Med advisory board]."},{"name":"John A Zic,
MD","credentials":["Section Editor — Cutaneous Lymphoma\n","Associate Professor of
Medicine/Dermatology\n","Vanderbilt University School of
Medicine"],"disclosure":"Other Financial Interest: Response Review Committee Member
Icon; Imaging Millennium [Treatment of advanced stage (IIB to IV) mycosis fungoides
(Brentuximab vedotin)]."},{"name":"John J Zone, MD","credentials":["Section Editor
— Bullous Disease\n","Professor and Chairman, Department of
Dermatology\n","University of Utah"],"disclosure":""}]},{"name":"Editorial
Assistants","contributors":[{"name":"Mark Gilbert, MA","credentials":["Editorial
Assistant – UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":
[{"name":"Sumaira Z Aasi, MD","credentials":["Professor\n","Department of
Dermatology\n","Stanford University School of Medicine"],"disclosure":""},
{"name":"Ossama Abbas, MD","credentials":["Assistant Professor, Department of
Dermatology\n","American University of Beirut Medical Center"],"disclosure":""},
{"name":"David R Adams, MD, PharmD","credentials":["Associate Professor of
Dermatology\n","Penn State Hershey Med Center"],"disclosure":""},{"name":"Denise
Adams, MD","credentials":["Co-Director of the Vascular Anomalies Center, Division
of Hematology/Oncology\n","Associate Professor\n","Harvard Medical
School"],"disclosure":""},{"name":"Cem Akin, MD, PhD","credentials":["Professor of
Medicine \n","University of Michigan"],"disclosure":"Consultant/Advisory Boards:
Deciphera [Mastocytosis]; Patara Pharma [Mastocytosis (Cromolyn)]; Novartis
[Mastocytosis (Midostaurin)]. Patent Holder: LAD2 cell line [Mast cells]."},
{"name":"Mary A Albrecht, MD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Macrene Alexiades,
MD, PhD","credentials":["Associate Clinical Professor\n","Yale University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Serene Medical
[Facial aesthetic laser treatments]; DUSA Pharmaceuticals Inc. [Photodynamic
Therapy (Aminolevulinic acid HCl)]; DEKA Research and Development Corp. [Fractional
lasers (Dermal optical thermolysis laser)]. Consultant/Advisory Boards: Allergan
[Facial aesthetics (Botulinum toxin type A, hyaluronic acid fillers)]."},
{"name":"Andrew F Alexis, MD, MPH","credentials":["Associate Professor\n","Icahn
School of Medicine, Mt. Sinai St. Luke's and Roosevelt
Hospitals"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan
[Hyperpigmentation (Skin-brightening cream)]. Consultant/Advisory Board: Roche
[Dissecting cellulitis (Isotretinoin)]; Amgen [Dissecting cellulitis (Etanercept)];
Galderma [Melasma (Hydroquinone, fluocinolone acetonide, tretinoin cream)];
Allergan [Hyperpigmentation (Skin-brightening cream)]."},{"name":"Patrick C
Alguire, MD, FACP","credentials":["Senior Vice President Emeritus for Medical
Education\n","American College of Physicians"],"disclosure":""},{"name":"Shawn
Allen, MD","credentials":["Assistant Clinical Professor, Department of
Dermatology\n","University of Colorado\n","Director, Dermatology Specialists of
Boulder, PC Boulder, CO"],"disclosure":"Consultant/Advisory Boards: Galderma [Nerve
injury (Botulinum toxin)]."},{"name":"Iris Amitay-Laish, MD","credentials":
["Lecturer, Department of Dermatology\n","Rabin Medical Center, Beilinson Hospital,
Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,
Israel"],"disclosure":""},{"name":"Karl E Anderson, MD, FACP","credentials":
["Professor\n","The University of Texas Medical
Branch"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam
Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute
porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria].
Consultant/Advisory Boards: Alnylam Pharmaceuticals [Acute porphyrias (RNAi
therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe
Pharma America [Protoporphyria]; Moderna Therapeutics [Acute porphyrias]."},
{"name":"Grant J Anhalt, MD","credentials":["Professor of Dermatology and
Pathology\n","Johns Hopkins University, School of Medicine"],"disclosure":""},
{"name":"Giuseppe Argenziano, MD","credentials":["Associate Professor and
Coordinator of the Skin Cancer Unit\n","Arcispedale S. Maria Nuova IRCCS, Reggio
Emilia"],"disclosure":""},{"name":"April W Armstrong, MD, MPH","credentials":
["Associate Dean for Clinical Research\n","Department of Dermatology\n","University
of Southern California"],"disclosure":"Grant/Research/Clinical Trial Support:
Amgen; AbbVie; Janssen; Eli Lilly and Company [Psoriasis (Etanercept, adalimumab,
ustekinumab, ixekizumab)]. Speaker's Bureau: AbbVie; Eli Lilly and Company; Janssen
[Psoriasis (Adalimumab, ixekizumab, guselkumab)]. Consultant/Advisory Boards:
AbbVie; Janssen; Pfizer; Celgene; Novartis; Eli Lilly and Company; Sanofi;
Regeneron [Psoriasis (Adalimumab, ustekinumab, tofacitinib, apremilast,
tildrakizumab, ixekizumab, dupilumab)]."},{"name":"Kenneth A Arndt,
MD","credentials":["Clinical Professor of Dermatology, Emeritus\n","Harvard Medical
School"],"disclosure":""},{"name":"Stephanie J Arnold, FACD, MBBS (Hons), BSc
(Hons)","credentials":["Consultant Dermatologist\n","Churchill Hospital Department
of Dermatology, Oxford"],"disclosure":""},{"name":"Riccardo Asero,
MD","credentials":["Head Ambulatorio di Allergologia\n","Clinica San Carlo, Paderno
Dugnano (MI), Italy"],"disclosure":""},{"name":"Maryam Asgari, MD,
MPH","credentials":["Associate Professor\n","Massachusetts General Hospital at
Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support:
Pfizer [Psoriasis (Anti-tumor necrosis factor-alpha inhibitor,
immunosuppressants)]; Valeant [Atopic dermatitis (Pimecrolimus, topical
corticosteroid, topical calcineurin inhibitor)]."},{"name":"Jon C Aster,
MD","credentials":["Professor of Pathology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic
malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch
inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis
[Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options:
Cellestia; Anastasis."},{"name":"Larry M Baddour, MD, FIDSA, FAHA","credentials":
["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Armita Bahrami, MD","credentials":["St. Jude Children’s Research
Hospital\n","University of Tennessee Health Science Center"],"disclosure":""},
{"name":"Yevgeniy Balagula, MD","credentials":["Assistant Professor\n","Division of
Dermatology\n","Montefiore Medical Center"],"disclosure":""},{"name":"Aleena
Banerji, MD","credentials":["Associate Professor\n","Training Program
Director\n","Massachusetts General Hospital"],"disclosure":"Grant/Research/Clinical
Trial Support: Shire [Hereditary angioedema (Icatibant)]; CSL [Hereditary
angioedema (Cinryze, Berinert)]. Consultant/Advisory Boards: Shire [Hereditary
angioedema (Icatibant)]; Alnylam [Hereditary angioedema]; CSL [Hereditary
angioedema (Berinert)]; Biocryst [Hereditary angioedema (No product FDA approved
yet)]."},{"name":"Benjamin Barankin, MD, FRCPC","credentials":["Dermatologist,
Medical Director \n","Toronto Dermatology Centre, Toronto,
Canada"],"disclosure":""},{"name":"Raymond L Barnhill, MD","credentials":
["Professor of Pathology\n","Department of Pathology, Institut
Curie"],"disclosure":"Grant/Research/Clinical Trial Support: Myriad Genetics, Inc.
[Melanoma (Gene signature analysis)]. Consultant/Advisory Boards: Myriad Genetics,
Inc. [Melanoma (Gene signature analysis)]."},{"name":"Elma D Baron,
MD","credentials":["Professor of Dermatology\n","Case Western Reserve
University"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix, Inc.
[CTCL (Hypericin for PDT)]. Consultant/Advisory Boards: Biofronterra [PDT (ALA
patch for PDT)]."},{"name":"Priya Batra, MD","credentials":["Attending
physician\n","Mt. Sinai Hospital"],"disclosure":""},{"name":"Johann Bauer,
MD","credentials":["Professor and Chair of Dermatology and
Venereology\n","Paracelsus Medical University Salzburg"],"disclosure":"Equity
Ownership/Stock Options: Diaderm [Epidermolysis bullosa (Diacerein)]."},
{"name":"Christian L Baum, MD","credentials":["Assistant Professor, Department of
Dermatology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support:
Dermatology Foundation [Cutaneous squamous cell carcinoma, chronic lymphocytic
leukemia, non-Hodgkin lymphoma]."},{"name":"Theresa Becker, DO","credentials":
["Assistant
Professor of Pediatrics\n","Harvard Medical School\n","Medical Director, Pediatric
Programs Lahey Beverly\n","Executive Network Director\n","Division of Emergency
Medicine"],"disclosure":""},{"name":"Latanya T Benjamin, MD","credentials":
["Pediatric Dermatologist\n","Joe DiMaggio Children's Hospital"],"disclosure":""},
{"name":"Wilma Bergfeld, MD","credentials":["Professor of Dermatology and
Pathology\n","Cleveland Clinic\n","Clinical Associate Professor of
Dermatology\n","Lerner Medical School and Case Western Reserve Medical
School"],"disclosure":"Consultant/Advisory Boards: Johnson & Johnson [Hair loss
(Minoxidil)]; Samumed [Topical investigational study]; Incyte [Topical
investigational study]."},{"name":"Diane Berson, MD","credentials":["Assistant
Clinical Professor of Dermatology\n","Weill Medical College of Cornell
University"],"disclosure":"Consultant/Advisory Boards: Allergan [Acne (Antioxidants
and anti-inflammatory)]; Merz [Acne (Antioxidants and anti-inflammatory)]; Illumask
[Acne (Antioxidants and anti-inflammatory)]; Procter and Gamble [Cosmecueticals];
TopMD [Acne (Antioxidants and anti-inflammatory)]."},{"name":"Neal Bhatia,
MD","credentials":["Director of Clinical Dermatology\n","Therapeutics Clinical
Research"],"disclosure":"Grant/Research/Clinical Trial Support: Viamet
[Onychomycosis]. Speaker's Bureau: Anacor, Valeant [Onychomycosis].
Consultant/Advisory Boards: Anacor, Valeant [Onychomycosis]."},{"name":"Andreas J
Bircher, MD","credentials":["Professor of Dermatology\n","University Hospital,
Basel, Switzerland"],"disclosure":"Consultant/Advisory Boards: Accord Healthcare;
Acino Pharma; Arrow Génériques; Claris Lifesciences; Generis Farmacéutica;
Genfarma/Genéricos Españoles; Laboratoires Sterop; MEDICE Arzneimittel Pütter;
Mesama Consulting; Mylan; Orifarm Generics; PanMedica; Pharmachemie; Pharmacosmos;
Rafarm; Sandoz; Sanofi Aventis Group; Vifor Pharma [Hypersensitivity reactions
(Intravenous iron products)]."},{"name":"Andrew Blauvelt, MD, MBA","credentials":
["President and Investigator\n","Oregon Medical Research
Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis
(Adalimumab and risankizumab)]; Amgen [Psoriasis (Etanercept)]; Boehringer
Ingelheim Pharmaceuticals [Psoriasis (Risankizumab)]; Celgene Corporation
[Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab pegol)]; Eli Lily
[Psoriasis (Ixekizumab and baricitinib)]; Genentech [Atopic dermatitis
(Lebrikizumab)]; GlaxoSmithKline [Atopic dermatitis (Mepolizumab)]; Janssen
Pharmaceuticals [Psoriasis (Ustekinumab and guselkumab)]; Leo Pharma [Atopic
dermatitis (Tralokinumab)]; Merck [Psoriasis (Tildrakizumab)]; Novartis [Psoriasis
(Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; Regeneron Pharmaceuticals [Atopic
dermatitis (Dupilumab)]; Sandoz [Psoriasis (Biosimilar adalimumab)]; Sanofi Genzyme
[Atopic dermatitis (Dupilumab)]; Sun Pharmaceutical Industries [Psoriasis
(Tildrakizumab)]; UCB [Psoriasis (Certolizumab pegol and bimekizumab)]; Valeant
Pharmaceuticals International [Psoriasis (Brodalumab)]. Speaker's Bureau: Eli Lily
[Psoriasis (Ixekizumab and baricitinib)]; Janssen Pharmaceuticals [Psoriasis
(Ustekinumab and guselkumab)]; Regeneron Pharmaceuticals [Atopic dermatitis
(Dupilumab)]; Sanofi Genzyme [Atopic dermatitis (Dupilumab)]. Consultant/Advisory
Boards: AbbVie [Psoriasis (Adalimumab and risankizumab)]; Amgen [Psoriasis
(Etanercept)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Risankizumab)];
Celgene Corporation [Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab
pegol)]; Eli Lily [Psoriasis (Ixekizumab and baricitinib)]; Genentech [Atopic
dermatitis (Lebrikizumab)]; GlaxoSmithKline [Atopic Dermatitis (Mepolizumab)];
Janssen Pharmaceuticals [Psoriasis (Ustekinumab and guselkumab)]; Leo Pharma
[Atopic dermatitis (Tralokinumab)]; Merck [Psoriasis (Tildrakizumab)]; Novartis
[Psoriasis (Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; Regeneron
Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Sandoz [Psoriasis (Biosimilar
adalimumab)]; Sanofi Genzyme [Atopic dermatitis (Dupilumab)]; Sun Pharmaceutical
Industries [Psoriasis (Tildrakizumab)]; UCB [Psoriasis (Certolizumab pegol and
bimekizumab)]; Valeant Pharmaceuticals International [Psoriasis (Brodalumab)]."},
{"name":"Andreas Blum, MD, MSc","credentials":["Associate Professor of Dermatology
- Faculty of Medicine\n","University of Tuebingen, Germany"],"disclosure":""},
{"name":"John B Bodensteiner, MD","credentials":["Senior Associate Consultant in
Child and Adolescent Neurology\n","Mayo Clinic College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Ionis (Isis) Pharmaceuticals
[SMA DSMB]; American Board of Psychiatry and Neurology [Director]."},{"name":"Kim
Bohjanen, MD","credentials":["Associate Professor\n","University of
Minnesota"],"disclosure":""},{"name":"Jean L Bolognia, MD","credentials":
["Professor of Dermatology\n","Yale University School of
Medicine"],"disclosure":""},{"name":"Alexandro Bonifaz, MD","credentials":
["Professor and Senior Researcher\n","Hospital General de
México"],"disclosure":""},{"name":"Laurence M Boon, MD, PhD","credentials":
["Coordinator of the Center for Vascular Malformations\n","Division of Plastic
Surgery\n","Cliniques Universitaires St Luc, Catholic University of
Louvain"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":["Assistant
Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Sylvia Brice, MD","credentials":["Associate Professor of
Dermatology\n","University of Colorado Denver, School of
Medicine"],"disclosure":""},{"name":"Bruce A Brod, MD","credentials":["Clinical
Professor of Dermatology\n","University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Robert T Brodell, MD","credentials":
["Professor and Chair, Department of Dermatology\n","Professor of
Pathology\n","University of Mississippi Medical Center"],"disclosure":""},
{"name":"Anna L Bruckner, MD","credentials":["Associate Professor of Dermatology
and Pediatrics\n","University of Colorado School of Medicine, Aurora,
CO"],"disclosure":""},{"name":"Giovanna Brunasso, MD","credentials":["First Level
Medical Director\n","Department of Dermatology\n","Galliera
Hospital"],"disclosure":""},{"name":"Bettina Burger, DSc","credentials":["Head of
Research Laboratory of Dermatology\n","University of Basel"],"disclosure":""},
{"name":"Antonio C Buzaid, MD","credentials":["General Medical Director,
\n","Centro Oncologico Antonio Ermirio de Moraes, \n","BP de Sao Paulo,
Brazil\n","Steering Committee Member,\n","Centro Oncológico do Hospital Israelita
Albert Einstein, \n","Sao Paulo, Brazil"],"disclosure":""},{"name":"David Cabral,
MBBS, FRCPC","credentials":["Clinical Professor of Pediatrics, Head, Division of
Rheumatology, Department of Pediatrics\n","University of British
Columbia"],"disclosure":""},{"name":"Valerie D Callender, MD, FAAD","credentials":
["Associate Professor of Dermatology\n","Howard University College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Acne/PIH,
melasma (Tazarotene)]; Galderma [Acne/PIH, melasma (4%HQ/tretinoin/fluocinolone)];
Bayer [Acne/PIH, melasma (Azelaic acid 15% gel)]. Consultant/Advisory Boards:
Allergan [Acne (Topical dapsone)]; Galderma [Acne (Adapalene/BPO)]."},
{"name":"Kristina Callis Duffin, MD","credentials":["Section Editor —
Psoriasis\n","Associate Professor, Department of Dermatology\n","University of
Utah"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Psoriasis
(Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene
Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab
and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company
[Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen
Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)];
Stiefel Laboratories [Psoriasis (Calcipotriene)]. Consultant/Advisory Boards: Amgen
[Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)];
Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis
(Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers
Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)];
Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and
infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]."},{"name":"Judith R
Campbell, MD","credentials":["Professor of Pediatric Infectious Diseases\n","Baylor
College of Medicine"],"disclosure":""},{"name":"Adela Rambi G Cardones,
MD","credentials":["Associate Professor\n","Duke University"],"disclosure":""},
{"name":"Alastair Carruthers, FRCPC","credentials":["Clinical Professor, Department
of Dermatology and Skin Science\n","University of British
Columbia"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan, Inc.
[BoNTA and fillers (OnabotulinumtoxinA, hyaluronic acid gel); Merz and Revance
[BoNTA and fillers (IncobotulinumtoxinA, dermal filler, calcium hydroxylapatite,
injectable botulinum toxin investigational product)]. Consultant/Advisory Boards:
Kythera BioPharma [Submental fullness (Deoxycholic acid)]; Allergan, Inc.
[Submental fullness (Deoxycholic acid)]; Merz [Submental fullness (Deoxycholic
acid)]; Revance [Neuromodulators (Neuromodulators)]. Grant/Research/Clinical Trial
Support (Spouse): Allergan Pharmaceuticals [Neuromodulators and fillers
(OnabotulinumtoxinA)]; Merz USA and Merz GmBH [Neuromodulators and fillers
(Hyaluronic acid)]; Kythera BioPharma [Sodium deoxycholate (Deoxycholate)].
Consultant/Advisory Boards (Spouse): Allergan Pharmaceuticals [Neuromodulators and
fillers (OnabotulinumtoxinA)]; Merz USA and Merz GmBH [Neuromodulators and fillers
(Hyaluronic acid)]; Kythera BioPharma [Sodium deoxycholate (Deoxycholate)]."},
{"name":"Jean Carruthers,
MD, FRCSC","credentials":["Clinical Professor, Department of Ophthalmology and
Visual Sciences\n","University of British
Columbia"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan
Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)];
Revance Therapeutics Inc. [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon
Corporation [Neuromodulators (BotulinumtoxinA)]; Zeltiq Aesthetics Inc. [Arm/body
sculpting (Cryopolysis)]. Grant/Research/Clinical Trial Support (Spouse): Allergan
Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)];
Revance Therapeutics Inc. [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon
Corporation [Neuromodulators (BotulinumtoxinA)]. Consultant/Advisory Boards:
Allergan Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium
deoxycholate)]; Bonti [Neuromodulators (Botulinum toxin E)]; Revance
[Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon [Neuromodulators
(BotulinumtoxinA)]; Zeltiq Aesthetics Inc. [Arm/body sculpting (Cryopolysis)].
Consultant/Advisory Boards (Spouse): Allergan Pharmaceuticals [Neuromodulators
(OnabotulinumtoxinA, sodium deoxycholate)]; Revance Therapeutics Inc.
[Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon Corporation [Neuromodulators
(BotulinumtoxinA)]."},{"name":"Mariana C Castells, MD, PhD","credentials":
["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Felipe Bochnia Cerci, MD","credentials":["Assistant
Professor\n","Department of Dermatology, Hospital Santa Casa de
Curitiba"],"disclosure":""},{"name":"Amy Y-Y Chen, MD, FAAD","credentials":
["Assistant Professor, Department of Dermatology\n","University of Connecticut
School of Medicine"],"disclosure":""},{"name":"Mei Chen, PhD","credentials":
["Professor and Director of Research - Department of Dermatology\n","University of
Southern California"],"disclosure":""},{"name":"Karen A Chernoff,
MD","credentials":["Assistant Professor of Dermatology and Pediatrics\n","Weill
Cornell Medical College"],"disclosure":""},{"name":"Anna L Chien,
MD","credentials":["Assistant Professor of Dermatology\n","Johns Hopkins School of
Medicine"],"disclosure":""},{"name":"Keith Choate, MD, PhD","credentials":
["Associate Professor of Dermatology, Genetics, and Pathology\n","Yale University
School of Medicine"],"disclosure":"Speaker's Bureau: AbbVie [Psoriasis
(Adalimumab)]; Janssen [Psoriasis (Ustekinumab)]."},{"name":"Chia-Yu Chu, MD,
PhD","credentials":["Associate Professor - Department of Dermatology\n","National
Taiwan University Hospital"],"disclosure":""},{"name":"Derek H Chu,
MD","credentials":["Clinical Assistant Professor\n","Department of Dermatology,
Stanford University"],"disclosure":""},{"name":"Antonio A T Chuh, MD, FRCP,
FRCPCH","credentials":["Adjunct Clinical Assistant Professor\n","JC School of
Public Health\n","The Chinese University of Hong Kong and the Prince of Wales
Hospital Hong Kong"],"disclosure":""},{"name":"Marco Cicardi, MD","credentials":
["Professor of Medicine\n","Università degli Studi di Milano,
Italy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; CSL Behring;
Pharming; BioCryst [Hereditary angioedema (Icatibant, plasma-derived C1INH,
recombinant human C1INH, lanadelumab)]. Speaker's Bureau: Shire; CSL Behring;
Pharming [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human
C1INH)]. Consultant/Advisory Boards: Shire; CSL Behring; BioCryst; Pharvaris;
KalVista [Hereditary angioedema (Lanadelumab, subcutaneous C1INH, avoralstat, oral
anti-bradykinin, oral anti-kallikrein)]."},{"name":"Jennie Clarke,
MD","credentials":["Associate Professor of Dermatology\n","University of Utah
Health Science Center"],"disclosure":""},{"name":"Susan M Cooper, MB ChB, MRCGP,
FRCP, MD","credentials":["Consultant Dermatologist and Honorary Senior Clinical
Lecturer\n","Oxford University Hospitals"],"disclosure":""},{"name":"Rosamaria
Corona, MD, DSc","credentials":["Deputy Editor — Dermatology"],"disclosure":""},
{"name":"Edward W Cowen, MD, MHSc","credentials":["Senior Clinician and Head,
Dermatology Consultation Service\n","Dermatology Branch, National Institute of
Arthritis and Musculoskeletal and Skin Diseases\n","National Institutes of
Health"],"disclosure":""},{"name":"Clara Curiel-Lewandrowski, MD","credentials":
["Associate Professor of Dermatology\n","Arizona Cancer Center, University of
Arizona"],"disclosure":""},{"name":"Mark V Dahl, MD","credentials":["Section Editor
— Acne and Rosacea\n","Professor Emeritus\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Mark DP Davis, MD","credentials":["Professor
of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Fatma Dedeoglu, MD","credentials":["Assistant Professor of
Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Christopher P
Denton, MD","credentials":["Professor of Experimental Rheumatology\n","Royal Free
Hospital, London"],"disclosure":"Grant/Research/Clinical Trial Support:
GlaxoSmithKline [Scleroderma, pulmonary hypertension (Ambrisentan, epoprostenol)];
Inventiva [Scleroderma, pulmonary hypertension]; Roche [Scleroderma, pulmonary
hypertension]; CSL Behring [Scleroderma, pulmonary hypertension]; Sanofi-Aventis
[Scleroderma]. Consultant/Advisory Boards: GlaxoSmithKline [Scleroderma, pulmonary
hypertension (Ambrisentan, epoprostenol)]; Inventiva [Scleroderma, pulmonary
hypertension]; Roche [Scleroderma, pulmonary hypertension]; Actelion [Scleroderma,
pulmonary hypertension (Bosentan, macitentan)]; Boehringer Ingelheim [Scleroderma];
Bayer [Scleroderma, pulmonary hypertension (Riociguat)]; EMD Serono [Scleroderma];
Medac [Scleroderma]."},{"name":"Jennifer A DeSimone, MD","credentials":["Assistant
Professor\n","Georgetown University Department of Dermatology\n","Director,
Cutaneous Lymphoma Program and Transplant Dermatology\n","Inova Melanoma and Skin
Cancer Center"],"disclosure":""},{"name":"Clio Dessinioti, MD","credentials":
["Attending Physician\n","Department of Dermatology, Medical School, University of
Athens, A.Syggros Hospital"],"disclosure":""},{"name":"John P Dice,
MD","credentials":["Allergy and Immunology\n","Private
Practice"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Sanofi;
TEVA Pharmaceuticals; AstraZeneca; GlaxoSmithKline; Perrigo; DBV Technologies.
Speaker's Bureau: TEVA Pharmaceuticals [Asthma, allergy (Beclomethasone
dipropionate, albuterol sulfate)]."},{"name":"Jeff Donovan, MD, PhD","credentials":
["Assistant Professor of Medicine\n","University of Toronto"],"disclosure":""},
{"name":"Jeffrey S Dover, MD, FRCPC","credentials":["Section Editor — Cosmetic
Dermatology\n","Associate Clinical Professor of Dermatology\n","Yale University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan;
Evolus; Valeant Pharmaceuticals [Neuromodulators, fillers]; Cutera; Cynosure;
Lumenis; Syneron; Valeant Pharmaceuticals [Lasers, lights]; Merz [Toxin, filler];
Shaser Bioscience [Intense pulse light hair removal (Hair removal device)]; Zeltiq
Aesthetics [Body contouring (Fat loss system)]; Revance [Neuromodulator]; Sienna
[Lasers]. Consultant/Advisory Boards: Maison de Beaute; Web MD; Sky Biodevices;
Syneron; Shaser Bioscience; Cutera; Cynosure; Lumenis; Valeant Pharmaceuticals
[Lasers, lights]; Kythera Biopharmaceuticals [Fat saponification]; Myoscience
[Neuromuscular]; Topokine Therapeutics [Fat modulation (Biologics)]; Zeltiq
Aesthetics [Body contouring (Fat loss system)]; Valeant Pharmaceuticals [Fillers,
toxin]; Sienna [Lasers]. Equity Ownership/Stock Options: CVS/Skin Effects [Skin
care]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)];
Sky Biodevices [Skin cancer screening]. Other Financial Interest: Cynosure;
Lumenis; Syneron [Use of equipment (Lasers, lights)]."},{"name":"Kathleen A Downey,
MD","credentials":["Associate Clinical Professor of Family Medicine\n","University
of Cincinnati"],"disclosure":""},{"name":"Jonathan A Dyer, MD","credentials":
["Assistant Professor of Dermatology and Child Health - Department of
Dermatology\n","University of Missouri"],"disclosure":"Grant/Research/Clinical
Trial Support: Crown Therapeutics [Ichthyosis vulgaris (Topical lotion)]."},
{"name":"Benjamin D Ehst, MD, PhD","credentials":["Clinical Associate
Professor\n","Oregon Health & Science University, Portland,
OR"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen Pharmaceutica;
AbbVie; Pfizer; Eli Lilly and Company; UCB; Boehringer Ingelheim; Novartis; Merck;
Dermira [Psoriasis (Tofacitinib, ixekizumab, guselkumab, bimekizumab, risankizumab,
secukinumab, tildrakizumab, certolizumab pegol)]. Speaker's Bureau: Novartis; Eli
Lilly and Company [Psoriasis (Secukinumab, ixekizumab)]. Consultant/Advisory
Boards: Novartis; Eli Lilly and Company [Psoriasis (Secukinumab, ixekizumab)]."},
{"name":"Craig A Elmets, MD","credentials":["Section Editor —
Photodermatology\n","Professor and Chair of Dermatology\n","University of Alabama
at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Solgenix [CTCL
(SGX301)]; Kyowa Hakko USA [CTCL (Mogamulizumab)]; CA Assn of Wine Growers
[Photoprotection (Grapes)]; Ferndale Labs [Photoprotection (Polypodium
leukotomos)]; Elorac [CTCL (Topical Naloxone]); Idera [Dermatomyositis (IMO-8400)].
Consultant/Advisory Boards: Ferndale Labs [Photoprotection (Polypodium
leukotomos)]; Astellas Pharma US [Data Safety Monitoring Board - Atopic Dermatitis
(Tacrolimus)]. Equity Ownership/Stock Options: Aevi Genomic Medicine (Gene
therapy); Vaxin (Topical vaccines)."},{"name":"Dirk M Elston, MD","credentials":
["Professor and Chair, Department of Dermatology and Dermatologic
Surgery\n","Medical University of South Carolina"],"disclosure":""},{"name":"S Jean
Emans, MD","credentials":["Mary Allen Avery Professor of Pediatrics\n","Harvard
Medical School"],"disclosure":""},{"name":"Rüdiger Eming, MD","credentials":
["Senior
Physician and Group Leader - Department of Dermatology and
Allergology\n","Philipps-Universität, Marburg
Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Fresenius Medical
Care [Pemphigus (Immunosorba, Globaffin)]; Biotest [Autoimmune blistering diseases
(Immunoglobulins)]. Speaker's Bureau: Fresenius Medical Care [Pemphigus
(Immunosorba, Globaffin)]; Biotest [Autoimmune blistering diseases
(Immunoglobulins)]; Novartis [Psoriasis]."},{"name":"Sara B Fazio,
MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Brian M Feldman, MD, MSc, FRCPC","credentials":
["Professor of Pediatrics\n","University of Toronto"],"disclosure":"Other Financial
Interest: Pfizer; BMS; Novartis; Optum; Ability [DSMB member for JIA studies]."},
{"name":"Steven R Feldman, MD, PhD","credentials":["Professor\n","Wake Forest
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Galderma
[Psoriasis (Clobetasol, calcitriol)]; National Biological Corporation [Psoriasis
(Phototherapy equipment)] Pfizer [Psoriasis (Tofacitinib)]; Novartis [Psoriasis
(Secukinumab)]; Lilly [Psoriasis (Ixekizumab)]; Taro [Psoriasis (Desoximetasone)].
Speaker's Bureau: Janssen [Psoriasis (Ustekinumab, infliximab, golimumab)]; Celgene
[Psoriasis (Apremilast)]; Novartis [Psoriasis (Secukinumab)]; Lilly [Psoriasis
(Ixekizumab)] Pfizer [Psoriasis (tofacitinib)]; Valeant [Psoriasis, (brodalumab)].
Consultant/Advisory Boards: Galderma [Psoriasis (Clobetasol, calcitriol)];
GSK/Stiefel [Psoriasis (Acitretin)]; Leo Pharma [Psoriasis (Betamethasone,
calcipotriene)]; Celgene [Psoriasis (Apremilast)]; Pfizer [Psoriasis
(Tofacitinib)]; AbbVie [Psoriasis (Adalimumab)]; Merck [Psoriasis]; Valeant
[Psoriasis (Brodalumab)]; Lilly [Psoriasis (Ixekizumab)]."},{"name":"Alisa N Femia,
MD","credentials":["Assistant Professor \n","The Ronald O. Perelman Department of
Dermatology\n","New York University Langone Medical Center"],"disclosure":""},
{"name":"Kristen H Fernandez, MD","credentials":["Assistant
Professor\n","University of Missouri, Columbia"],"disclosure":""},{"name":"Nicole
Fett, MD","credentials":["Associate Professor\n","Oregon Health and Science
University"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer
[Dermatomyositis (Interferon, beta 1, fibroblast blocker)]; F. Hoffmann-La Roche
[Pemphigus vulgaris (Rituximab, mycophenolate mofetil)]."},{"name":"Andrew
Fontenot, MD","credentials":["Henry N. Claman Professor of Medicine, Division Head,
Allergy and Clinical Immunology\n","University of Colorado, School of
Medicine"],"disclosure":""},{"name":"Stephen Foster, MD","credentials":["Clinical
Professor of Ophthalmology\n","Harvard Medical School"],"disclosure":""},
{"name":"Fabio Francesconi, MD","credentials":["Assistant Professor of
Dermatology\n","Amazon Federal University - Medicine\n","Clinical Researcher;
Coordinator - Dermatology Residence Program\n","Tropical Medicine Foundation Dr.
Heitor Vieira Dourado"],"disclosure":""},{"name":"Michael M Frank,
MD","credentials":["Samuel L. Katz Professor of Pediatrics\n","Duke University
Medical Center"],"disclosure":"Consultant/Advisory Boards: BioCryst [Data and
safety monitoring board hereditary angioedema drugs]; Shire [Data and safety
monitoring board hereditary angioedema drugs]."},{"name":"Anthony F Fransway,
MD","credentials":["Associates in Dermatology MD's, LLC\n","Fort Myers,
FL"],"disclosure":""},{"name":"Arnold S Freedman, MD","credentials":["Section
Editor — Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard
Medical School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB].
Other Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer
17833)]."},{"name":"Ilona J Frieden, MD","credentials":["Professor of Dermatology
and Pediatrics\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards: Pierre Fabre Dermatology
[Infantile hemangiomas (Propranolol liquid formulation)]."},{"name":"Maxwell A
Fung, MD","credentials":["Professor of Clinical Dermatology and
Pathology\n","Department of Dermatology\n","University of California Davis School
of Medicine"],"disclosure":""},{"name":"Sheila Galbraith, MD","credentials":["Mayo
Clinic Health System\n","Eau Claire, Wisconsin"],"disclosure":""},{"name":"Amit
Garg, MD, FAAD","credentials":["Professor - Department of Dermatology\n","Donald
and Barbara Zucker School of Medicine at
Hofstra/Northwell"],"disclosure":"Grant/Research/Clinical Trial Support: Merk
[Alzheimer disease (Drug in development)]; AbbVie [Hidradenitis suppurativa
(Adalimumab)]. Consultant/Advisory Boards: AbbVie [Hidradenitis suppurativa
(Adalimumab)]; Asana Biosciences [Atopic dermatitis]."},{"name":"Anthony Gaspari,
MD","credentials":["Chief, Section of Dermatology\n","Lancaster General
Hospital"],"disclosure":""},{"name":"Alan C Geller, RN, MPH","credentials":["Senior
Lecturer\n","Social and Behavioral Sciences\n","Harvard School of Public
Health"],"disclosure":""},{"name":"Shamir Geller, MD","credentials":["Senior
physician - Department of Dermatology at Tel Aviv Sourasky Medical Center\n","Tel
Aviv University's Sackler Medical School"],"disclosure":""},{"name":"Jeffrey E
Gershenwald, MD, FACS","credentials":["Professor of Surgery and Cancer
Biology\n","The University of Texas MD Anderson Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Merck [Melanoma therapy
(Pembrolizumab, interferonxx)]."},{"name":"Larisa J Geskin, MD","credentials":
["Associate Professor of Dermatology in Medicine\n","Columbia
University"],"disclosure":""},{"name":"David J Goldberg, MD","credentials":
["Clinical Professor of Dermatology and Director of Laser Research \n","Mount Sinai
School of Medicine, New York, NY"],"disclosure":""},{"name":"Lynne J Goldberg,
MD","credentials":["Professor of Dermatology and Pathology and Laboratory
Medicine\n","Boston University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Hair growth]; Living
Proof."},{"name":"Gary Goldenberg, MD","credentials":["Assistant Professor of
Dermatology and Pathology\n","Mount Sinai School of Medicine\n","Medical Director
of the Dermatology Faculty Practice"],"disclosure":""},{"name":"Ronald Goldner,
MD","credentials":["Clinical Professor of Dermatology\n","University of Maryland
Baltimore, School of Medicine"],"disclosure":""},{"name":"Adam O Goldstein, MD,
MPH","credentials":["Professor\n","Department of Family Medicine\n","University of
North Carolina at Chapel Hill"],"disclosure":""},{"name":"Beth G Goldstein,
MD","credentials":["Adjunct Clinical Assistant Professor\n","Department of
Dermatology\n","University of North Carolina at Chapel Hill"],"disclosure":""},
{"name":"Erika Gonzalez-Reyes, MD","credentials":["Associate Professor of
Pediatrics\n","Baylor College of Medicine"],"disclosure":"Speaker’s Bureau:
Novartis (Omalizumab therapy). Consultant/Advisory Boards\t: Genentech (Omalizumab
therapy)."},{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic
Institute at Cleveland Clinic\n","Center for Vasculitis Care and Research at
Cleveland clinic"],"disclosure":""},{"name":"Jason Gotlib, MD, MS","credentials":
["Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell
leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)];
Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab
vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline
Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)].
Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint
Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Emmy Graber, MD,
MBA","credentials":["Clinical Instructor\n","Northeastern
University"],"disclosure":"Speaker's Bureau: Allergan [Acne (Topical dapsone)].
Consultant/Advisory Boards: Hovione [Acne (Topical minocycline)]."},{"name":"Pearl
E Grimes, MD","credentials":["Clinical Professor of Dermatology\n","University Of
California, Los Angeles"],"disclosure":""},{"name":"Deepti Gupta,
MD","credentials":["Assistant Professor of Pediatrics (Dermatology)\n","Department
of Pediatrics and Division of Dermatology\n","Seattle Children's
Hospital\n","University of Washington School of Medicine"],"disclosure":""},
{"name":"Autumn Chandler Guyer, MD","credentials":["Assistant Clinical Professor of
Medicine\n","University of California San Francisco"],"disclosure":""},{"name":"M.
Tye Haeberle, MD","credentials":["Clinical Instructor\n","Division of Dermatology,
University of Louisville"],"disclosure":""},{"name":"Russell P Hall, III,
MD","credentials":["J Lamar Callaway Professor and Chair, Department of
Dermatology\n","Duke University Medical Center"],"disclosure":""},{"name":"Allan
Halpern, MD, MSc","credentials":["Member\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":"Consultant/Advisory Boards: Canfield Scientific, Inc.
[Atypical nevi (Photography systems)]; Caliber Imaging and Diagnostics [Atypical
nevi (Confocal microscopes)]."},{"name":"Jennifer L Hand, MD","credentials":
["Section Editor — Genodermatoses\n","Associate Professor of Dermatology, Medical
Genetics, and Pediatrics\n","Mayo Clinic, Rochester, MN"],"disclosure":""},
{"name":"Evangeline B Handog, MD","credentials":["Chair, Department of
Dermatology\n","Asian Hospital and Medical Center"],"disclosure":""},
{"name":"Allison M Hanlon, MD","credentials":["Assistant Professor\n","Division of
Dermatology\n","Mohs Dermatologic Surgery\n","Department of Medicine\n","Vanderbilt
University"],"disclosure":""},{"name":"Cristina Has, MD","credentials":["Department
of Dermatology,\n","Medical Center - University of Freiburg,
Germany"],"disclosure":""},{"name":"Jason
E Hawkes, MD","credentials":["Instructor in Clinical Investigation\n","Laboratory
for Investigative Dermatology, Rockefeller University"],"disclosure":""},
{"name":"Elena B Hawryluk, MD, PhD","credentials":["Assistant Professor\n","Harvard
Medical School"],"disclosure":"Patent Holder (Spouse): Foundation Medicine [Genetic
testing for cancer]. Employment (Spouse): Foundation Medicine [Genetic testing for
cancer]; Gritstone Oncology [Personalized cancer immunotherapy]. Equity
Ownership/Stock Options (Spouse): Foundation Medicine [Genetic testing for cancer];
Gritstone Oncology [Personalized cancer immunotherapy]."},{"name":"Michael Hertl,
MD","credentials":["Professor and Chairman - Department of Dermatology and
Allergology\n","Philipps-Universität, Marburg
Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Biotest
Pharmaceuticals Corporation [Pemphigus (Immunoglobulin G)]; Fresenius [Pemphigus
(Immunoadsorption device)]. Speaker’s Bureau: Janssen-Cilag [General
immunodermatology, bullous diseases (Ustekinumab)]. Consultant/Advisory Boards:
Novartis [Psoriasis, immunodermatology, academic mentoring programs
(Secukinumab)]."},{"name":"Whitney A High, MD","credentials":["Associate Professor
of Dermatology and Dermatopathology\n","University of Colorado School of
Medicine"],"disclosure":""},{"name":"Emmilia Hodak, MD","credentials":["Head,
Department of Dermatology\n","Rabin Medical Center, Beilinson Hospital, Petah
Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,
Israel"],"disclosure":"Speaker's Bureau: Actelion Pharmaceuticals Ltd [Mycosis
fungoides (Topical mechlorethamine, nitrogen mustard)]. Consultant/Advisory Boards:
Actelion Pharmaceuticals Ltd [Mycosis fungoides (Topical mechlorethamine, nitrogen
mustard)]."},{"name":"Daniel Hohl, MD","credentials":["Full Professor\n","Lausanne
University Hospital"],"disclosure":""},{"name":"Herbert Hönigsmann,
MD","credentials":["Professor of Dermatology, Emeritus Chairman \n","Medical
University of Vienna"],"disclosure":""},{"name":"Richard T Hoppe,
MD","credentials":["Professor of Radiation Oncology\n","Stanford University School
of Medicine"],"disclosure":""},{"name":"Maria Hordinsky, MD","credentials":
["Section Editor — Hair and Scalp Disease\n","Chair and Professor - Department of
Dermatology\n","University of Minnesota Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte Corporation
[Alopecia areata (Topical Janus kinase inhibitor)]; Allergan [Male pattern baldness
(Setipiprant tablets)]; Pfizer [Alopecia areata (Oral Janus kinase inhibitor)].
Consultant/Advisory Boards: Concert Pharmaceuticals [Alopecia areata (Oral Janus
kinase inhibitor)]; BiologicsMD [Alopecia, androgenetic alopecia (Hair cycle
stimulator, subcutaneous injection)]; Bionz [Alopecia areata]. Other financial
interest: Pantene Institute/Proctor & Gamble (Hair care products)."},
{"name":"Kimberly A Horii, MD","credentials":["Professor of
Pediatrics\n","University of Missouri-Kansas City School of Medicine, Children's
Mercy Hospital"],"disclosure":""},{"name":"Steven Horwitz, MD","credentials":
["Associate Attending\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene Corporation
[mycosis fungoides (romidepsin)]; Millennium Pharmaceuticals/Takeda [Hodgkin
lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin [mycosis fungoides
(mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma (brentuximab vedotin)];
Spectrum Pharmaceuticals [mycosis fungoides (pralatrexate)]; Forty-Seven;
Infinity/Verastem; ADCT Therapeutics; Aileron Therapeutics. Consultant/Advisory
Boards: Celgene Corporation; Millennium Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin;
Seattle Genetics; Forty-Seven; Infinity/Verastem; HUYA; BMA; Mundipharma."},
{"name":"Eric W Hossler, MD","credentials":["Associate\n","Departments of
Dermatology and Pathology\n","Geisinger Medical Center"],"disclosure":""},
{"name":"William Howe, MD","credentials":["Assistant Clinical
Professor\n","University of Colorado Denver School of Medicine"],"disclosure":""},
{"name":"George J Hruza, MD","credentials":["Adjunct Professor of Dermatology and
Otolaryngology\n","St. Louis University School of Medicine"],"disclosure":""},
{"name":"Christopher Hull, MD","credentials":["Associate Professor, Department of
Dermatology\n","University of Utah"],"disclosure":""},{"name":"C Scott Hultman, MD,
MBA, FACS","credentials":["Ethel and James Valone Distinguished Professor of
Surgery; Division Chief and Program Director\n","UNC Plastic
Surgery"],"disclosure":""},{"name":"Shannon Humphrey, MD, FRCPC,
FAAD","credentials":["Clinical Assistant Professor, Department of Dermatology and
Skin Science\n","University of British Columbia"],"disclosure":"Grant/Research
Support: Allergan [Injectable drug targeting submental fullness (Deoxycholic
acid)]; Zeltiq [Arm/body sculpting (Cryolipolysis)]; Cutanea Life Sciences [Rosacea
(Topical treatment)]; Revance Therapeutics; Evolus [Acne (Neuromodulator)].
Speaker's Bureau: Allergan [Cosmetic dermatology (Neuromodulators, fillers)];
Galderma; L'Oreal [Acne, rosacea (Topical acne and rosacea treatments)].
Consultant/Advisory Boards: Allergan [Cosmetic dermatology (Neuromodulators,
fillers)]; Galderma; L'Oreal [Skinboosters; skincare (Topical acne and rosacea
treatments)]; L'Oreal; Merz; BonTi; Zeltiq [Skincare (Neuromodulator,
cryolipolysis)]."},{"name":"Raegan Hunt, MD, PhD","credentials":["Assistant
Professor of Dermatology and Pediatrics\n","Texas Children's Hospital\n","Baylor
College of Medicine"],"disclosure":""},{"name":"Sameera Husain, MD","credentials":
["Associate Professor of Dermatology in Pathology\n","Columbia University Medical
Center"],"disclosure":""},{"name":"Clare Hutchinson, MDCM, FRCPC","credentials":
["Pediatric Rheumatologist\n","University of Toronto"],"disclosure":""},
{"name":"John R Ingram, MD, PhD","credentials":["Senior Lecturer and Consultant
Dermatologist\n","Division of Infection and Immunity\n","Cardiff University,
Cardiff, United Kingdom"],"disclosure":"Grant/Research/Clinical Trial Support:
AbbVie [Hidradenitis suppurativa (Adalimumab)]. Speaker's Bureau: AbbVie
[Hidradenitis suppurativa (Adalimumab)]; UCB Pharm [Hidradenitis suppurativa].
Other Financial Interest: British Journal of Dermatology [Editorial stipend]."},
{"name":"Stuart N Isaacs, MD","credentials":["Associate Professor\n","Perelman
School of Medicine at the University of Pennsylvania"],"disclosure":""},
{"name":"Geoffrey K Isbister, MD","credentials":["Professor, Clinical Toxicology
Research Group\n","University of Newcastle, Australia"],"disclosure":""},
{"name":"Peter Itin, MD","credentials":["Head of Department of
Dermatology\n","University of Basel"],"disclosure":""},{"name":"Jeremy D Jackson,
MD","credentials":["Associate Professor of Dermatology\n","University of
Mississippi Medical Center"],"disclosure":""},{"name":"Heidi Jacobe,
MD","credentials":["Associate Professor of Dermatology\n","University of Texas
Southwestern"],"disclosure":""},{"name":"Eric Jacobsen, MD","credentials":
["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene
[Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards: Seattle Genetics [T
cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma (Pralatrexate,
romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},{"name":"Jared
Jagdeo, MD, MS","credentials":["Associate Professor of Dermatology\n","University
of California, Davis"],"disclosure":""},{"name":"Natalia Jaimes, MD","credentials":
["Assistant Professor\n","Miller School of Medicine, University of
Miami"],"disclosure":""},{"name":"Natasha R Johnson, MD","credentials":["Assistant
Professor in Obstetrics, Gynecology and Reproductive Biology\n","Harvard Medical
School"],"disclosure":""},{"name":"Joseph Jorizzo, MD","credentials":["Professor
and Former (Founding) Chair\n","Wake Forest University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Psoriasis]."},
{"name":"Marshall E Kadin, MD","credentials":["Professor of Dermatology\n","Boston
University School of Medicine"],"disclosure":""},{"name":"Robert E Kalb,
MD","credentials":["Clinical Professor of Dermatology\n","State University of New
York at Buffalo"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie
[Psoriasis (Adalimumab)]; Amgen [Psoriasis (Etanercept)]; Boehringer Ingelheim
[Psoriasis]; Janssen [Psoriasis (Ustekinumab)]; LEO Pharma [Psoriasis (Taclonex)];
Merck [Psoriasis]; Novartis [Psoriasis (Secukinumab)].Consultant/Advisory Boards:
AbbVie [Psoriasis (Adalimumab)]; Dermira [Psoriasis (Certolizumab)] Janssen
[Psoriasis (Ustekinumab)]; Eli Lilly [Psoriasis (Ixekizumab)]; Sun Pharmaceuticals
[Psoriasis (Tildrakizumab)]."},{"name":"Sewon Kang, MD","credentials":["Noxell
Professor & Chair, Department of Dermatology\n","Johns Hopkins School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Unilever [Skin
aging]; L'Oreal [Skin aging]. Consultant/Advisory Boards: Unilever [Skin barrier];
L'Oreal [Skin aging]. Patent Holder: Co-inventor [Skin aging, patent owned by
University of Michigan]."},{"name":"Souha S Kanj, MD","credentials":["Professor of
Medicine\n","Head, Division of Infectious Diseases,\n","Chairperson, Infection
Control Program\n","American University of Beirut Medical
Center"],"disclosure":"Speaker's Bureau: Merck [Antibiotics
(Ceftolozane/tazobactam)]. Consultant/Advisory Boards: Merck [Antibiotics
(Ceftolozane/tazobactam)]."},{"name":"Pritesh S Karia, MPH","credentials":["Manager
- Dermatologic Oncology Research Program\n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"Andreas Katsambas, MD","credentials":
["Professor of Dermatology\n","University of Athens"],"disclosure":""},
{"name":"Stephen Kells, PhD","credentials":["Associate Professor of
Entomology\n","University of Minnesota"],"disclosure":""},{"name":"Kristen
M Kelly, MD","credentials":["Professor of Dermatology and Surgery \n","University
of California Irvine"],"disclosure":"Grant/Research/Clinical Trial Support:
Allergan [Rosacea (Oxymetazoline hydrochloride cream)]; Novartis [Breast, kidney,
lung, and pancreatic cancer (Everolimus)]; Syneron-Candela [Vascular lesions,
rosacea, pigmented lesions (Pulsed dye laser)]; ThermiGen [Cosmetic therapy
(Temperature-controlled radiofrequency devices)]. Consultant/Advisory Boards:
Allergan [Rosacea (Oxymetazoline hydrochloride cream)]; Syneron-Candela [Vascular
lesions, rosacea, pigmented lesions (Pulsed dye laser)]."},{"name":"Robert Kelly,
MD","credentials":["Head of Clinical Dermatology, Department of Dermatology\n","St
Vincent’s Hospital / Melbourne University"],"disclosure":""},{"name":"David A Khan,
MD","credentials":["Professor of Medicine and Pediatrics\n","UT Southwestern
Medical Center"],"disclosure":"Speaker's Bureau: Genentech [Urticaria
(Omalizumab)]. Consultant/Advisory Boards: Aimmune [Food allergy]."},
{"name":"Nonhlanhla P Khumalo, MBChB, FCDerm, PhD","credentials":["Professor, Head
of Dermatology\n","Groote Schuur Hospital and The University of Cape
Town"],"disclosure":""},{"name":"Abdul-Ghani Kibbi, MD, FACP, FAAD","credentials":
["Professor and Chair, Department of Dermatology\n","American University of Beirut
Medical Center"],"disclosure":""},{"name":"Ellen J Kim, MD","credentials":
["Associate Professor of Dermatology\n","Perelman School of Medicine at the
University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support:
Kyowa Hakko Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761,
mogamulizumab])]; Solgenix [CTCL clinical trial investigator (hypericin
photodynamic topical agent)]; Actelion [CTCL clinical trial investigator (nitrogen
mustard gel)]. Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard
gel)]."},{"name":"Gene Kim, MD","credentials":["Assistant Professor of Pathology
and Dermatology\n","University of Southern California"],"disclosure":""},
{"name":"Jinah Kim, MD","credentials":["Assistant Professor of
Dermatology\n","Stanford University"],"disclosure":""},{"name":"Susan Kim, MD,
MMSc","credentials":["Associate Professor of Pediatrics\n","University of
California, San Francisco"],"disclosure":""},{"name":"Youn H Kim,
MD","credentials":["Professor of Dermatology\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL
(E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL
(Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle
Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)],
Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL
(IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL],
Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma
[CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL
(Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven
Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL
(Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Talmadge
E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care
Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of
Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San
Francisco"],"disclosure":""},{"name":"Robyn S Klein, MD, PhD","credentials":
["Associate Professor of Medicine\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Hiroshi Koga, MD","credentials":["Assistant
Professor of Dermatology\n","Shinshu University School of
Medicine"],"disclosure":""},{"name":"Michihiro Kono, MD, PhD","credentials":
["Associate Professor, Department of Dermatology\n","Nagoya University Graduate
School of Medicine"],"disclosure":""},{"name":"John Koo, MD","credentials":
["Professor of Clinical Dermatology\n","University of California San
Francisco"],"disclosure":""},{"name":"Neil Korman, MD, PhD","credentials":
["Professor of Dermatology\n","Case Western Reserve University"],"disclosure":""},
{"name":"Arianne Shadi Kourosh, MD","credentials":["Director of Community
Health\n","Department of Dermatology, Massachusetts General Hospital and Harvard
Medical School"],"disclosure":""},{"name":"Alexander Kreuter, MD","credentials":
["Head of the Department of Dermatology\n","HELIOS St. Elisabeth
Hospital"],"disclosure":"Consultant/Advisory Boards: Sanofi Pasteur [Human
papillomavirus (Human papillomavirus 9-valent vaccine)]; Merck Sharp & Dohme Corp.
[Human papillomavirus (Human papillomavirus 9-valent vaccine)]; Novartis
International AG [Psoriasis (Secukinumab)]; AbbVie [Hidradenitis suppurativa
(Adalimumab)]. Other Financial Interest: Actelion Pharmaceuticals, Ltd. [Systemic
sclerosis (Bosentan)]."},{"name":"Daniela Kroshinsky, MD","credentials":["Assistant
Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},
{"name":"Jean Krutmann, MD","credentials":["Professor of Dermatology &
Environmental Medicine, Director \n","IUF – Leibniz-Institut für umweltmedizinische
Forschung an der Heinrich-Heine-University Duesseldorf, Germany"],"disclosure":""},
{"name":"Roopal Kundu, MD","credentials":["Associate Professor of Dermatology and
Medical Education\n","Northwestern University, Feinberg School of
Medicine"],"disclosure":""},{"name":"Kelly KyungHwa Park, MD","credentials":["Mohs
Micrographic Surgery and Dermatologic Oncology Fellow\n","Skin Institute of South
Florida"],"disclosure":""},{"name":"Mario E Lacouture, MD","credentials":
["Associate Professor of Medicine \n","Cornell University\n","Member\n","Memorial
Hospital\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Berg [Rash
(Calcitriol)]; Bristol-Myers Squibb [Rash (Cetuximab)]. Consultant/Advisory Boards:
Quintiles [Rash (Anti-epidermal growth factor receptor monoclonal antibody
mixture)]; Boehringer Ingelheim [Rash (Afatinib)]; AstraZeneca [Rash
(Osimertinib)]; Foamix Pharmaceuticals [Rash (Doxycycline)]; Novartis [Rash
(Alpelisib)]; Novocure [Rash (Device used to treat glioblastoma multiforme)]."},
{"name":"Martin Laimer, MD","credentials":["Associate Professor of Dermatology and
Venereology \n","Paracelsus Medical University
Salzburg"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Bristol-
Myers Squibb [Melanoma (Talimogene laherparepvec, pembrolizumab, ipilimumab,
nivolumab)]."},{"name":"Tahaniyat Lalani, MBBS, MHS","credentials":["Associate
Professor\n","Uniformed Services University of the Health
Sciences"],"disclosure":""},{"name":"Megan N Landis, MD","credentials":["Assistant
Clinical Professor of Dermatology\n","University of Louisville School of
Medicine"],"disclosure":""},{"name":"Fiona Larsen, MBChB, FRACP","credentials":
["Dermatologist"],"disclosure":""},{"name":"Marc R Laufer, MD","credentials":
["Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: AbbVie [Endometriosis
(Elagolix)]; Nextjane Gen [Endometriosis (test)]."},{"name":"Leslie P Lawley,
MD","credentials":["Assistant Professor of Dermatology\n","Emory University School
of Medicine"],"disclosure":""},{"name":"Ronald Laxer, MD, FRCPC","credentials":
["Professor of Pediatrics\n","University of
Toronto"],"disclosure":"Grant/Research/Clinical Trial Support: Scleroderma Society
of Ontario [Morphea (Studies)]."},{"name":"Erica Lee, MD","credentials":
["Instructor of Dermatology\n","Weill Cornell Medical College"],"disclosure":""},
{"name":"Lela Lee, MD","credentials":["Clinical Professor of
Dermatology\n","University of Colorado School of Medicine"],"disclosure":""},
{"name":"Kristin M Leiferman, MD","credentials":["Professor of
Dermatology\n","University of Utah"],"disclosure":"Employment: University of Utah
Department of Dermatology, Co-Director Immunodermatology Laboratory [Pemphigoid
(Immunoassays performed for the diagnosis of immunobullous diseases)]."},
{"name":"Alexander KC Leung, MBBS, FRCPC, FRCP (UK & Ireland), FRCPCH,
FAAP","credentials":["Clinical Professor of Pediatrics\n","University of
Calgary"],"disclosure":""},{"name":"Moise L Levy, MD","credentials":["Section
Editor — Pediatric Dermatology\n","Professor of Pediatrics and Medicine
(Dermatology)\n","Dell Medical School, University of Texas, Austin\n","Clinical
Professor of Dermatology and Pediatrics\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Anacor
Pharmaceuticals [Atopic dermatitis (Investigational drug)]; Scioderm [Epidermolysis
bullosa (Topical treatment investigation)]. Speaker's Bureau: Anacor
Pharmaceuticals [Atopic dermatitis (Investigational drug)]. Consultant/Advisory
Boards: Castle Creek Pharmaceuticals [Epidermolysis bullosa (New drug in
development)]. Patent Holder: Incontinentia pigmenti (NEMO gene mutations)."},
{"name":"Jean Lee Lim, MD","credentials":["Department of Dermatology\n","Kaiser
Permanente Medical Group, Santa Rosa, CA"],"disclosure":""},{"name":"Marilyn Ling,
MD","credentials":["Associate Professor\n","Department of Radiation
Oncology\n","University of Rochester Medical Center"],"disclosure":""},
{"name":"Peter A Lio, MD","credentials":["Clinical Assistant Professor of
Dermatology and Pediatrics\n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AOBiome [Atopic
dermatitis (Topical probiotic spray)]. Speaker's Bureau: Regeneron Pharmaceuticals
[Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)].
Consultant/Advisory Boards: Sanofi [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic
dermatitis (Crisaborole)]; Realm Therapeutics [Atopic dermatitis (Future
medication)]."},{"name":"Dan Lipsker,
MD, PhD","credentials":["Medical Faculty\n","University of
Strasbourg"],"disclosure":""},{"name":"Vincent Liu, MD","credentials":["Clinical
Professor\n","Departments of Dermatology and Pathology\n","University of Iowa
Carver College of Medicine"],"disclosure":""},{"name":"Fred A Lopez,
MD","credentials":["Richard Vial Professor and Vice Chair\n","Louisiana State
University School of Medicine"],"disclosure":""},{"name":"Emily Broun Lund,
MD","credentials":["University of Chicago"],"disclosure":""},{"name":"David Mabey,
BM, BCh, DM, FRCP","credentials":["Professor of Communicable Diseases\n","London
School of Hygiene and Tropical Medicine"],"disclosure":""},{"name":"Maria Juliet E
Macarayo, MD","credentials":["Consultant, Department of Dermatology\n","Angeles
University Foundation Medical Center"],"disclosure":"Speaker's Bureau: Galderma
Philippines [Acne, atopic dermatitis, eczema, rosacea (Adapalene and benzoyl
peroxide, adapalene, skin cleanser, moisturizing cream, brimonidine, desonide)];
Menarini Group [Seborrheic dermatitis, atopic dermatitis, eczema, acne, urticaria
(Acne prevention cream, acne prevention gel, acne prevention ointment, nonsteroidal
cream for eczema, antihistamine, nonsteroidal cream for seborrheic dermatitis)];
LEO Pharma [Infectious diseases, psoriasis (Fusidic acid, psoriasis gel and
cream)]; Brady Pharma [Pigmentary disorders (Pigmentation removal products)];
Glenmark Philippines [Atopic dermatitis, psoriasis, eczema, acne (Halobetasol,
adapalene, tacrolimus)]. Consultant/Advisory Boards: Acne Board of the Philippines
[Acne (Acne products and dermocosmetics)]."},{"name":"Jennifer L MacGregor,
MD","credentials":["Clinical Professor of Dermatology\n","Columbia University
Medical Center, New York"],"disclosure":"Consultant/Advisory Boards: Allergan
[Rosacea (oxymetazoline hydrochloride cream 1%)]."},{"name":"Julian M Mackay-
Wiggan, MD, MS","credentials":["Associate Professor of Dermatology\n","Columbia
University Medical Center"],"disclosure":""},{"name":"Ian A Maher,
MD","credentials":["Assistant Professor\n","Department of Dermatology, Saint Louis
University"],"disclosure":""},{"name":"Mary Maiberger, MD","credentials":
["Associate Professor of Dermatology\n","Howard University\n","Associate Clinical
Professor of Dermatology"],"disclosure":""},{"name":"Lisa E Maier,
MD","credentials":["Clinical Associate Professor, Department of
Dermatology\n","University of Washington\n","Adjunct, Department of
Dermatology\n","University of Michigan"],"disclosure":""},{"name":"Mary E Maloney,
MD","credentials":["Professor of Medicine (Dermatology)\n","University of
Massachusetts Medical School"],"disclosure":""},{"name":"Erin N Marcus, MD, MPH,
FACP","credentials":["Associate Professor of Clinical Medicine\n","University of
Miami Miller School of Medicine"],"disclosure":""},{"name":"Ashfaq A Marghoob,
MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"James G Marks, Jr, MD","credentials":["Professor
and Chair, Department of Dermatology\n","Penn State Milton S. Hershey Medical
Center"],"disclosure":""},{"name":"Jose Dario Martinez Villarreal,
MD","credentials":["Professor of Internal Medicine and Dermatology\n","University
Hospital, Universidad Autonoma de Nuevo Leon, School of
Medicine"],"disclosure":""},{"name":"Renato G Martins, MD, MPH","credentials":
["Medical Director\n","Professor\n","University of Washington\n","Seattle Cancer
Care Alliance"],"disclosure":""},{"name":"Cesare Massone, MD","credentials":
["Medical Director, Dermatology Unit\n","Galliera Hospital, Genova,
Italy\n","Associate Professor, Department of Dermatology\n","Medical University of
Graz, Graz, Austria"],"disclosure":""},{"name":"Barbara M Mathes, MD, FACP,
FAAD","credentials":["Clinical Associate, Dermatology\n","University of
Pennsylvania\n","Secretary Treasurer\n","American Academy of
Dermatology"],"disclosure":""},{"name":"Erin Mathes, MD","credentials":["Associate
Professor of Dermatology\n","Departments of Dermatology and
Pediatrics\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards: Zosano Pharma [Migraine (Drug
delivery device)]; Rodan & Fields (Cosmetics); Laboratoires Pierre Fabre
[Hemangioma (Propranolol hydrochloride)]."},{"name":"Marcus Maurer,
MD","credentials":["Professor of Dermatology and Allergy\n","Charité –
Universitätsmedizin Berlin, Germany"],"disclosure":"Grant/Research/Clinical Trial
Support: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)];
Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES
[Urticaria (Bilastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria
(TempTest)]. Consultant/Advisory Boards: Novartis [Urticaria (Omalizumab)];
Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)]; Abbott
Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; MSD [Urticaria
(Desloratadine)]; Almirall [Urticaria (Ebastine)]; UCB [Urticaria
(Levocetirizine)]; Moxie [Urticaria (TempTest)]; Sanofi [Urticaria
(Fexofenadine)]."},{"name":"Toby Maurer, MD","credentials":["Professor of
Dermatology\n","University of California, San Francisco, School of
Medicine"],"disclosure":""},{"name":"Edward V Maytin, MD, PhD","credentials":
["Staff\n","Department of Dermatology, Cleveland
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Sun Pharmaceuticals
Industries [Photodynamic therapy (5-aminolevulinate)]. Consultant/Advisory Boards:
Sun Pharmaceuticals Industries [Photodynamic therapy (5-aminolevulinate)]."},
{"name":"Timothy H McCalmont, MD","credentials":["Professor of Dermatology and
Pathology\n","University of California, San Francisco"],"disclosure":""},
{"name":"Kenneth L McClain, MD, PhD","credentials":["Professor of
Pediatrics\n","Texas Children's Cancer Center/Hematology Service\n","Baylor College
of Medicine"],"disclosure":""},{"name":"Catherine McCuaig, MD","credentials":
["Associate Clinical Professor of Dermatology\n","University of
Montreal"],"disclosure":"Consultant/Advisory Boards: Johnson & Johnson [Aging, sun
protection (Water gel, broad spectrum sunscreen)]; Janssen Pharmaceutica [Psoriasis
(Infliximab)]; AbbVie [Psoriasis (Adalimumab)]; Novartis [Urticaria, psoriasis
(Omalizumab, secukinumab)]."},{"name":"Laura Y McGirt, MD","credentials":["Director
of Dermatologic Oncology\n","Levine Cancer Institute at Carolina's Medical Center,
Charlotte, North Carolina"],"disclosure":"Consultant/Advisory Boards: Actelion
[Parapsoriasis (Mechlorethamine)]; Mallinckrodt Pharmaceuticals [Parapsoriasis
(Extracorporeal photopheresis)]."},{"name":"Thomas McGovern, MD","credentials":
["Private Practice\n","Fort Wayne, IN"],"disclosure":""},{"name":"Beth N McLellan,
MD","credentials":["Assistant Professor\n","Albert Einstein College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Ferndale Pharma Group
[Radiation dermatitis (Polypodium leucotomos extract dietary supplement)]."},
{"name":"Amy McMichael, MD","credentials":["Professor of Dermatology\n","Wake
Forest University Baptist Medical Center"],"disclosure":"Grant/Research/Clinical
Trial Support: Allergan [Hair loss (Bimatoprost)]; Cassiopea [Hair loss]; Proctor &
Gamble [Hair loss (Age defy hair product)]; Samumed [Hair loss]. Consultant:
Aclaris; Cassiopea; eResearch Technology; Covance; Galderma; Guthey Renker; Incyte;
Keranetics; Merz Pharmaceuticals; Samumed [Hair loss]; Allergan [Hair loss
(Bimatoprost)]; Johnson & Johnson [Hair loss (Rogaine)]; Merck [Hair loss
(Propecia)]; Proctor & Gamble [Hair loss (Age defy hair product)]. Royalties:
Informa Healthcare [Hair loss]."},{"name":"Stephanie Mehlis, MD","credentials":
["Clinical Instructor, Division of Dermatology \n","University of Chicago, Pritzker
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Plaque psoriasis (Secukinumab)]; Janssen Pharmaceutica [Plaque psoriasis
(Guselkumab)]; Boehringer Ingelheim Pharmaceuticals, Inc. [Plaque psoriasis
(Risankizumab)]; Eli Lilly and Company [Plaque psoriasis (Ixekizumab)]. Speaker's
Bureau: Novartis [Psoriasis (Secukinumab)]. Consultant/Advisory Boards: Janssen
Pharmaceutica [Psoriasis (Ustekinumab and infliximab)]; Novartis [Psoriasis
(Secukinumab)]. Equity Ownership/Stock Options (Spouse): AbbVie Inc. [Plaque
psoriasis (Adalimumab)]; Johnson & Johnson [Psoriasis (Ustekinumab and
infliximab)]; Novartis [Psoriasis (Secukinumab)]."},{"name":"Joseph F Merola, MD,
MMSc, FAAD, FACR","credentials":["Assistant Professor, Harvard Medical
School\n","Department of Dermatology\n","Department of Medicine, Division of
Rheumatology \n","Brigham and Women's Hospital"],"disclosure":"Grant/Research
Support: Biogen [Cutaneous lupus erythematosus]; Pfizer [Psoriatic arthritis
(Tofacitinib)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Ustekinumab)]; Eli
Lily and Company [Psoriasis (Ixekizumab)]. Speakers Bureau: AbbVie [Psoriasis
(Adalimumab)]. Consultant/Advisory Boards: Biogen [Cutaneous lupus erythematosus];
AbbVie [Psoriasis, psoriatic arthritis (Adalimumab)]; Amgen [Psoriasis, psoriatic
arthritis (Etanercept)]; Eli Lilly and Company [Psoriasis, psoriatic arthritis
(Tofacitinib)]; Novartis [Psoriasis, psoriatic arthritis (Secukinumab)]; Pfizer
[Psoriasis, psoriatic arthritis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis,
psoriatic arthritis (Ustekinumab)]; Momenta Pharmaceuticals [Connective tissue
disease]; Mallinckrodt Pharmaceuticals [Psoriasis, psoriatic arthritis (Repository
corticotropin injection)]. Patent Holder: AbbVie [Psoriasis (Licensed outcome
measure)]."},{"name":"Andrew G Messenger, MD, FRCP","credentials":["Professor of
Dermatology\n","University of Sheffield"],"disclosure":""},{"name":"Andrei
Metelitsa, MD, FRCPC","credentials":["Clinical Assistant Professor, Division of
Dermatology\n","University of Calgary"],"disclosure":""},{"name":"Denise W Metry,
MD","credentials":["Associate Professor of Dermatology and Pediatrics\n","Baylor
College of Medicine"],"disclosure":""},{"name":"Robert G Micheletti,
MD","credentials":["Assistant Professor of Dermatology and Medicine\n","University
of Pennsylvania\n","Perelman School of Medicine"],"disclosure":""},{"name":"Barbara
Miedzybrodzki, MD","credentials":["Postgraduate Training-Fellow in Pediatric
Dermatology\n","Ste-Justine Hospital, University of Montreal"],"disclosure":""},
{"name":"Martin C Mihm, Jr, MD","credentials":["Clinical Professor of
Pathology\n","Harvard Medical School\n","Brigham and Women's
Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [Multiple tumor
therapies]; Alnylam [Question of allergic reaction to injected microRNA
conjugates]; MelaSciences [Clinical diagnosis in melanoma]; Caliber I.D. [Confocal
microscope diagnosis of tumors (Pre- and postbiopsy drugs)]; Biocoz [Skin
activation and wound recovery (Cutaneous lotion/moisturizer)]. Other Financial
Interest: John Wiley & Sons [Published book]."},{"name":"Daniel D Miller,
MD","credentials":["Assistant Professor\n","University of Minnesota Department of
Dermatology"],"disclosure":""},{"name":"Jami L Miller, MD","credentials":
["Assistant Professor of Medicine\n","Vanderbilt University"],"disclosure":""},
{"name":"Marc L Miller, MD","credentials":["Clinical Assistant Professor of
Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Paradi
Mirmirani, MD","credentials":["Department of Dermatology\n","The Permanente Medical
Group, Vallejo CA"],"disclosure":""},{"name":"Ginat W Mirowski, DMD,
MD","credentials":["Associate Professor\n","Department of Oral Pathology, Medicine,
and Radiology - Indiana University, School of Dentistry"],"disclosure":""},
{"name":"Dana Miskulin, MD","credentials":["Associate Professor\n","Tufts
University School of Medicine"],"disclosure":""},{"name":"Oriol Mitjà, MD, PhD,
DTMH","credentials":["Assistant Research Professor\n","Barcelona Institute for
Global Health, University of Barcelona"],"disclosure":""},{"name":"Sahil Mittal,
MD, MS","credentials":["Assistant Professor\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Kimberly Morishita, MD, MHSc,
FRCPC","credentials":["Clinical Assistant Professor of Pediatrics\n","Division of
Rheumatology, Department of Pediatrics\n","University of British
Columbia"],"disclosure":""},{"name":"Akimichi Morita, MD, PhD","credentials":
["Professor and Chairman, Department of Geriatric and Environmental
Dermatology\n","Nagoya City University Graduate School of Medical
Sciences"],"disclosure":""},{"name":"Dean Morrell, MD","credentials":["Associate
Professor, Department of Dermatology\n","University of North Carolina Chapel
Hill"],"disclosure":""},{"name":"Rachael Morris-Jones, FRCP, PhD,
PCME","credentials":["Dermatology Consultant and Associate Clinical Dean\n","King's
College Hospital and King's College London"],"disclosure":""},{"name":"Samuel L
Moschella, MD, FAAD, FACP","credentials":["Lahey Clinic"],"disclosure":""},
{"name":"Eliot Mostow, MD","credentials":["Professor and Chair, Dermatology
Section\n","Northeastern Ohio University College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Vivacare [Patient information
on web and app platforms]. Employment: Elsevier [Dermatology Assistant Editor,
practiceupdate.com]."},{"name":"Kiran Motaparthi, MD","credentials":["Assistant
Professor\n","Department of Dermatology\n","University of Florida College of
Medicine"],"disclosure":""},{"name":"Christen Mowad, MD","credentials":["Clinical
Professor\n","Temple University"],"disclosure":"Consultant/Advisory Boards:
PracticeUpdate."},{"name":"John C Murray, MD","credentials":["Professor of Medicine
(Dermatology)\n","Duke University Medical Center"],"disclosure":""},{"name":"Dedee
F Murrell, MD","credentials":["Professor and Chair of Dermatology, St. George
Hospital\n","University of New South Wales, Sydney,
Australia"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm/Amicus
Therapeutics [Epidermolysis bullosa (Allantoin)]; Castle Creek Pharmaceuticals LLC
[Epidermolysis bullosa simplex (Topical diacerein)]; Amryt Pharma [Epidermolysis
bullosa (Oleogel)]; Principia Biopharma [Pemphigus, bullous pemphigoid (Bruton's
tyrosine kinase inhibitor)]; Roche [Pemphigus, bullous pemphigoid (Rituximab)].
Consultant/Advisory Boards: Roche; Principia Biopharma; Immune Pharma; GSK
[Pemphigus, bullous pemphigoid (Rituximab, Bruton's tyrosine kinase inhibitor,
bertilimumab, ofatumumab)]."},{"name":"Amy Musiek, MD","credentials":["Assistant
Professor of Medicine\n","Washington University, St.
Louis"],"disclosure":"Speaker's Bureau: Actelion [Cutaneous T cell lymphoma
(Nitrogen mustard, mechlorethamine)]. Consultant/Advisory boards: Actelion
[Cutaneous T cell lymphoma (Nitrogen mustard, mechlorethamine)]; Kyowa Hakko Kirin
[Cutaneous T cell lymphoma (Mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma,
anaplastic large cell lymphoma (Brentuximab vedotin)]."},{"name":"Kishwer Nehal,
MD","credentials":["Associate Professor of Dermatology\n","Cornell Weill Medical
College"],"disclosure":""},{"name":"Megan H Noe, MD, MPH","credentials":["Clinical
Instructor and Postdoctoral Research Fellow\n","University of Pennsylvania
Department of Dermatology"],"disclosure":""},{"name":"Jeffrey P North,
MD","credentials":["Assistant Professor of Dermatology and Pathology\n","University
of California, San Francisco"],"disclosure":""},{"name":"Julia R Nunley,
MD","credentials":["Professor, Dermatology\n","Virginia Commonwealth University
School of Medicine"],"disclosure":""},{"name":"Abena O Ofori, MD","credentials":
["Deputy Editor — Dermatology\n","Assistant Professor of Medicine, Dermatology
Division\n","Medical College of Georgia"],"disclosure":""},{"name":"Sang Ho Oh, MD,
PhD","credentials":["Associate Professor\n","Department of Dermatology, Severance
Hospital, Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, Korea"],"disclosure":""},{"name":"Suzanne Olbricht,
MD","credentials":["Associate Professor of Dermatology\n","Harvard Medical
School"],"disclosure":""},{"name":"Dennis P Orgill, MD, PhD","credentials":
["Professor of Surgery\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Acelity [Wound
healing (VAC devices)]; Integra LifeSciences [Wound healing (Dermal regeneration
template)]; Musculoskeletal Research Foundation (Wound healing products).
Consultant/Advisory Boards: Acelity [Wound healing (VAC devices)]; Integra
LifeSciences [Wound healing (Dermal regeneration template)]; Musculoskeletal
Research Foundation (Wound healing products). Equity Ownership/Stock Options:
HyperMed (Perfusion monitoring systems)."},{"name":"Cindy Owen, MD","credentials":
["Assistant Professor of Medicine\n","University of Louisville"],"disclosure":""},
{"name":"R Steven Padilla, MD","credentials":["Professor of Dermatology &
Pathology\n","The University of New Mexico School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Athenex [Actinic keratosis
(Experimental ointment)]."},{"name":"Debra L Palazzi, MD, MEd","credentials":
["Associate Professor of Pediatrics, Infectious Diseases Section\n","Baylor College
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Invasive
fungal infections (Caspofungin, posaconazole)]; Durata [Antibiotic safety and PK
(Dalbavancin)]; Cempra [Antibiotic safety and PK (Solithromycin)].
Consultant/Advisory Boards: Pfizer [Antifungal trial data safety monitoring board
(Voriconazole, Anidulafungin)]. Other Financial Interest: JAMA Peds Associate
Editor [pediatrics (journal articles)]; AAP PREP ID Editorial board [PREP ID
educational products and course]."},{"name":"Amy S Paller, MD","credentials":
["Walter J. Hamlin Professor and Chair of Dermatology\n","Professor of
Pediatrics\n","Director, Northwestern University Skin Disease Research
Center\n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis
(Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company
[Psoriasis (Ixekizumab)]; Novartis [Psoriasis (Secukinumab)]. Consultant/Advisory
Boards: Amgen [Psoriasis (Etanercept)]; Celgene [Psoriasis (Apremilast)]; Eli Lilly
and Company [Psoriasis (Ixekizumab)]; Janssen Pharmaceutical [Psoriasis
(Ustekinumab)]; Novartis [Psoriasis (Secukinumab)]; Stiefel Laboratories [Psoriasis
(Calcipotriene)]."},{"name":"Alberto S Pappo, MD","credentials":["Section Editor —
Pediatric Oncology\n","Head of Solid Malignancies Program\n","St. Jude Children's
Research Hospital"],"disclosure":""},{"name":"Taraneh Paravar, MD","credentials":
["Assistant Professor, Department of Dermatology\n","University of California, San
Diego"],"disclosure":""},{"name":"David Pariser, MD","credentials":["Professor of
Dermatology\n","Eastern Virginia Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Brickell Biotech
[Hyperhidrosis]; Dermira [Hyperhidrosis]. Consultant/Advisory Boards: Brickell
Biotech [Hyperhidrosis]; Dermira [Hyperhidrosis]."},{"name":"Eva R Parker, MD,
FAAD","credentials":["Franklin Dermatology Group\n","Franklin,
TN"],"disclosure":""},{"name":"Aimee S Payne, MD, PhD","credentials":["Associate
Professor\n","Department of Dermatology\n","University of
Pennsylvania"],"disclosure":""},{"name":"Marta J Petersen, MD","credentials":
["Professor of Dermatology\n","University of Utah School of
Medicine"],"disclosure":""},{"name":"Josie A Pielop, MD","credentials":["Memorial
Dermatology \n","Houston, TX"],"disclosure":""},{"name":"Miriam Keltz Pomeranz,
MD","credentials":["Associate Professor of Dermatology\n","New York University
School of Medicine"],"disclosure":""},{"name":"Elena Pope, MD, MSc,
FRCPC","credentials":["Professor of Pediatrics\n","University of
Toronto"],"disclosure":""},{"name":"Lori
Prok, MD","credentials":["Assistant Professor of Dermatology and
Pediatrics\n","University of Colorado Denver School of Medicine"],"disclosure":""},
{"name":"Steven Prystowsky, MD","credentials":["Associate Professor\n","Department
of Dermatology\n","New York University School of Medicine"],"disclosure":""},
{"name":"Kate B Püttgen, MD, FAAD","credentials":["Assistant Professor of
Dermatology and Pediatrics\n","Johns Hopkins University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Pierre-Fabre [Infantile
hemangioma (propranolol)]."},{"name":"Flavio Queiroz-Telles, MD,
PhD","credentials":["Associate Professor\n","Department of Public Health, Hospital
de Clinicas\n","Federal University of Parana, Curitiba, Brazil"],"disclosure":""},
{"name":"Elizabeth Quigley, MD","credentials":["Assistant Professor of
Dermatology\n","Weill Medical College of Cornell University"],"disclosure":""},
{"name":"Leslie Raffini, MD","credentials":["Associate Professor of
Pediatrics\n","University of Pennsylvania"],"disclosure":""},{"name":"Priya
Rajendran, MD","credentials":["Clinical Instructor\n","University of California,
San Francisco"],"disclosure":""},{"name":"Mae Ramirez-Quizon, MD","credentials":
["Consultant\n","St. Luke's Medical Center, Global City,
Philippines"],"disclosure":""},{"name":"Caroline L Rao, MD","credentials":
["Associate Professor\n","Duke Department of Dermatology"],"disclosure":""},
{"name":"Jason Reichenberg, MD","credentials":["University of Texas Southwestern-
Austin Program"],"disclosure":""},{"name":"Anetta Reszko, MD","credentials":
["Assistant Professor of Dermatology\n","Weill Cornell Medical
Center"],"disclosure":""},{"name":"Phoebe Rich, MD","credentials":["Clinical
Associate Professor of Dermatology\n","Oregon Health Science
University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie [Psoriasis
(Biologic)]; Allergan [Rosacea (Topical)]; Amgen [Psoriasis (Biologic)]; Dusa
[Actinic (Topical)]; Eli Lilly [Keratosis (Biologic)]; Galderma [Psoriasis
(Topical)]; Janssen [AV, atopic (Biologic)]; Merck & Co [Psoriasis (Biologic)];
Novartis [Onychomycosis (Biologic)]; Pfizer [Actinic (Topical)]; Valeant [Psoriasis
(Topical)]; Viamet [AKs, tinea (Systemic)].\r\nConsultant/Advisory Boards: Novartis
[Psoriasis (Biologic)]; Allergan [Acne (Systemic)]."},{"name":"Elisabeth G Richard,
MD","credentials":["Assistant Professor of Dermatology\n","Johns Hopkins
University"],"disclosure":""},{"name":"Helge Riemann, MD","credentials":["Mid Coast
Dermatology, Brunswick, Maine"],"disclosure":""},{"name":"Simon A Ritchie,
MD","credentials":["Assistant Professor of Dermatology\n","Uniformed Services
University of the Health Sciences, Bethesda, MD"],"disclosure":""},{"name":"Mi
Ryung Roh, MD, PhD","credentials":["Associate Professor\n","Department of
Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research
Institute\n","Yonsei University College of Medicine, Seoul,
Korea"],"disclosure":""},{"name":"Thomas Rohrer, MD","credentials":["Clinical
Associate Professor, Department of Dermatology\n","Brown University School of
Medicine"],"disclosure":"Grant/Research Support: Merz Pharma [Toxins]. Speaker's
Bureau: Candela/Syneron [Lasers (Pigmented lesion lasers)]. Consultant/Advisory
Boards: Candela/Syneron [Lasers (Pigmented lesion lasers)]."},{"name":"Franco
Rongioletti, MD","credentials":["Professor and Chairman\n","Unit of
Dermatology\n","University of Cagliari, Italy"],"disclosure":""},{"name":"Alain H
Rook, MD","credentials":["Professor of Dermatology\n","Perelman School of Medicine
at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial
Support: Soligenix [CTCL research (hypericin clinical trial)]; Medimmune [CTCL
trial]; Galderma [CTCL trial]."},{"name":"Misha Rosenbach, MD","credentials":
["Assistant Professor of Dermatology and Internal Medicine\n","University of
Pennsylvania Perelman School of Medicine"],"disclosure":"Consultant/Advisory
Boards: Celgene [Sarcoidosis (Thalidomide, lenalidomide)]; Merck [Skin reactions,
granulomatous reactions (PD1 inhibitor)]; Processa Pharmaceuticals [Necrobiosis
lipoidica, granulomatous disease (Novel agent)]."},{"name":"Jean-Claude Roujeau,
MD","credentials":["Section Editor — Drug Eruptions\n","Emeritus Professor of
Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil,
France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis
(Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in
development)]."},{"name":"Beth S Ruben, MD","credentials":["Professor of
Dermatology and Pathology\n","University of California, San
Francisco"],"disclosure":""},{"name":"Michael R Rudnick, MD","credentials":
["Associate Professor of Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Julie L Ryan Wolf, PhD, MPH","credentials":
["Associate Professor, Departments of Dermatology and Radiation
Oncology\n","University of Rochester Medical Center"],"disclosure":""},
{"name":"Nazanin Saedi, MD","credentials":["Associate Professor of Dermatology and
Cutaneous Biology\n","Thomas Jefferson University"],"disclosure":"Speaker's Bureau:
Cynosure, Inc. [Lasers (Aesthetic picosecond laser)]; Solta Medical [Lasers
(Aesthetic picosecond laser)]."},{"name":"Toshiaki Saida, MD, PhD","credentials":
["Professor Emeritus\n","Shinshu University School of Medicine"],"disclosure":""},
{"name":"Sarbjit Saini, MD","credentials":["Section Editor — Urticaria and
Angioedema\n","Associate Professor of Medicine\n","Johns Hopkins University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Asthma, urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)].
Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune
[Urticaria (Omalizumab)]."},{"name":"Andrew D Samel, MD","credentials":["Affiliate
Staff Member\n","Sturdy Memorial Hospital"],"disclosure":""},{"name":"Liat
Samuelov, MD","credentials":["Senior Physician, Department of Dermatology\n","Tel
Aviv Sourasky Medical Center, Israel"],"disclosure":""},{"name":"Miguel Sanchez,
MD","credentials":["Associate Professor\n","Department of Dermatology\n","New York
University School of Medicine"],"disclosure":""},{"name":"Inbal Sander,
MD","credentials":["Assistant Professor\n","Johns Hopkins
University"],"disclosure":""},{"name":"Charles V Sanders, MD","credentials":["Edgar
Hull Professor and Chair\n","Louisiana State University School of Medicine New
Orleans"],"disclosure":"Equity Ownership/Stock Options: Baxter International,
Inc."},{"name":"Denis Sasseville, MD, FRCPC","credentials":["Professor of
Dermatology and Research Coordinator, Division of Dermatology\n","McGill University
Health Centre"],"disclosure":""},{"name":"Diane MF Savarese, MD","credentials":
["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology and Palliative
Care\n","Clinical Instructor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Courtney Schadt, MD","credentials":["Assistant
Professor\n","University of Louisville\n","Division of
Dermatology"],"disclosure":""},{"name":"Julie V Schaffer, MD","credentials":
["Attending in Pediatric Dermatology\n","Director, Pediatric Dermatology
Fellowship\n","Division of Pediatric & Adolescent Dermatology \n","Hackensack
University Medical Center"],"disclosure":""},{"name":"Peter C Schalock,
MD","credentials":["Adjunct Associate Professor of Dermatology (Surgery)\n","Geisel
School of Medicine, Dartmouth College"],"disclosure":""},{"name":"Noah Scheinfeld,
MD","credentials":["Assistant Clinical Professor of Dermatology\n","Weill Cornell
Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie
[Hidradenitis suppurativa (Adalimumab)]. Consultant/Advisory Boards: AbbVie
[Hidradenitis suppurativa (Adalimumab)]. Speaker’s Bureau: AbbVie [Hidradenitis
suppurativa (Adalimumab)]."},{"name":"Pamela L Scheinman, MD","credentials":
["Associate Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},
{"name":"Bethanee J Schlosser, MD, PhD","credentials":["Associate Professor -
Departments of Dermatology and Obstetrics/Gynecology\n","Northwestern University,
Feinberg School of Medicine"],"disclosure":""},{"name":"Chrysalyne D Schmults, MD,
MSCE","credentials":["Director of Mohs and Dermatologic Surgery and the High-Risk
Skin Cancer Clinic\n","Brigham and Women's/Dana Farber Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Basal cell
carcinoma (Vismodegib)]; Regeneron Pharmaceuticals [Cutaneous squamous cell
carcinoma (Investigational programmed cell death-1 drug)]; Novartis [Basal cell
carcinoma (Sonidegib)]. Consultant/Advisory Boards: Regeneron Pharmaceuticals
[Nonmelanoma skin cancer (Investigational programmed cell death-1 drug)]."},
{"name":"Sherry Scovell, MD, FACS","credentials":["Instructor in
Surgery\n","Harvard Medical School/Massachusetts General
Hospital"],"disclosure":""},{"name":"Emmanuel Seront, MD, PhD","credentials":
["Department of Medical Oncology \n","Institut Roi Albert II, Cliniques
Universitaires Saint-Luc, Catholic University of Louvain, Brussels,
Belgium"],"disclosure":""},{"name":"Daniel J Sexton, MD","credentials":["Editor-in-
Chief — Infectious Diseases\n","Section Editor — Bacterial Infections\n","Professor
of Medicine\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease
Control and Prevention; National Institutes of Health [Healthcare epidemiology].
Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical
Technologies [Medical diagnostics]; National Football League [Infection
prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock
Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture
techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related
infections]."},{"name":"Jerry
Shapiro, MD","credentials":["Professor - The Ronald O. Perelman Department of
Dermatology\n","New York University"],"disclosure":"Speaker's Bureau: Johnson and
Johnson [Hair regrowth (Hair regrowth topical solution product)]."},
{"name":"Michael P Sheehan, MD","credentials":["Volunteer Faculty\n","Indiana
University School of Medicine\n","Department of
Dermatology"],"disclosure":"Speaker's Bureau: Celgene [Psoriasis (Apremilast)].
Consultant/Advisory Boards: IntraDerm Pharmaceuticals [Contact dermatitis (HOCL
gel)]."},{"name":"Donald W Shenenberger, MD, FAAD, FAAFP","credentials":["Assistant
Professor of Dermatology\n","Eastern Virginia Medical School, Norfolk,
VA"],"disclosure":""},{"name":"Tetsuo Shiohara, MD, PhD","credentials":["Professor
and Chairman, Department of Dermatology \n","Kyorin University School of
Medicine"],"disclosure":""},{"name":"Robert Sidbury, MD, MPH","credentials":
["Professor - Department of Pediatrics\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm
[Epidermolysis bullosa (Investigational cream)]; Sanofi/Regeneron [Atopic
dermatitis (Investigational biologic)]. Consultant/Advisory Boards: Roche [Acne
(Accutane - no longer made)]; Pfizer [Atopic dermatitis (Crisaborole)]."},
{"name":"Dawn H Siegel, MD","credentials":["Associate Professor\n","Medical College
of Wisconsin"],"disclosure":""},{"name":"Olga Simionescu, MD, PhD","credentials":
["Professor and Head, 1st Clinic of Dermatology\n","Carol Davila University of
Medicine and Pharmacy"],"disclosure":""},{"name":"Ashwani K Singal, MD,
MS","credentials":["Associate Professor, Division of Gastroenterology and
Hepatology\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, ACG
[Porphyria, alcoholic liver disease]; Gilead Sciences, Aurora Pharmaceuticals
[Alcoholic steatohepatitis, nonalcoholic steatohepatitis]; Alnylam Pharmaceuticals
[Porphyria]. Consultant/Advisory Boards: Recordati [Porphyria (Hemin)]; Alnylam
[siRNA for ALAS-1]; Gilead Sciences [Hepatitis B virus, Hepatitis C virus,
nonalcoholic steatohepatitis]; Alexion Pharmaceuticals [Fatty liver disease].
Employment: UAB."},{"name":"Cassian Sitaru, MD","credentials":["Professor of
Dermatology\n","University of Freiburg"],"disclosure":""},{"name":"C Christopher
Smith, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Arthur J Sober, MD","credentials":["Professor of
Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Denis Spelman,
MBBS, FRACP, FRCPA, MPH","credentials":["Adjunct Professor, Monash
University\n","Alfred Hospital, Victoria, Australia"],"disclosure":""},
{"name":"Linda V Spencer, MD","credentials":["Spencer Dermatology Associates,
LLC\n","Crawfordsville, Indiana"],"disclosure":""},{"name":"Jonathan M Spergel, MD,
PhD, FAAAAI","credentials":["Professor of Pediatrics\n","University of Pennsylvania
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH;
AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis (Peanut powder)].
Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and peanut patch)].
Equity Ownership/Stock Options: DBV Technology [Peanut allergy (Milk and peanut
patch)]."},{"name":"Leonard C Sperling, MD","credentials":["Professor of
Dermatology and Pathology\n","Uniformed Services University"],"disclosure":""},
{"name":"Eli Sprecher, MD, PhD","credentials":["Chair and Professor, Department of
Dermatology\n","Tel Aviv Sourasky Medical Center, Israel"],"disclosure":""},
{"name":"Thomas Stasko, MD","credentials":["Professor and Chair - Department of
Dermatology\n","The University of Oklahoma Health Sciences
Center"],"disclosure":""},{"name":"Dennis L Stevens, MD, PhD","credentials":
["Professor of Medicine\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Basic
science (Tedizolid)]; Motif Bioscience [Basic science (Iclaprim)]."},
{"name":"Michael Stone, MD","credentials":["Chairman of Surgery\n","Stamford
Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Roche [Vasculitis
(Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related
disease (Xmab5871)]. Consultant/Advisory Boards: Roche [Vasculitis (Tocilizumab)];
Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related disease
(Xmab5871)]."},{"name":"Bruce E Strober, MD, PhD","credentials":["Professor and
Chair, Department of Dermatology\n","University of Connecticut Health
Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; Janssen
[Psoriasis, hidradenitis suppurativa, atopic dermatitis]; Boehringer Ingelheim
[Psoriasis (Interleukin-23 inhibitor)]; Celgene [Psoriasis (Apremilast)]; Novartis
[Psoriasis (Secukinumab)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Janssen
[Psoriasis (Guselkumab)]; Merck/Sun [Psoriasis (Tildrakizumab)]; Sienna
Biopharmaceuticals [Psoriasis (Future drug)]. Consultant/Advisory Boards: Sanofi-
Regeneron [Atopic dermatitis (Dupilumab)]; LEO Pharma [Atopic dermatitis (Future
drug)]; GlaxoSmithKline [Psoriasis (Future drug)]; AbbVie [Psoriasis (Adalimumab,
risankizumab)]; Almirall [Psoriasis (Tildrakizumab)]; Amgen [Psoriasis (Etanercept,
brodalumab)]; Boehringer Ingelheim [Psoriasis (IL-23 inhibitor)]; Celgene
[Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab)]; Janssen [Psoriasis
(Ustekinumab)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Maruho [Psoriasis
(Topical vitamin D)]; Medac [Psoriasis (methotrexate)]; Novartis [Psoriasis
(Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; UCB [Psoriasis (Certolizumab)].
Other Financial Interest: Scientific Director, Corrona Psoriasis Registry
[Psoriasis]."},{"name":"Todd Stultz, DDS, MD","credentials":["Staff, Section of
Neuroradiology\n","Imaging Institute\n","Cleveland Clinic"],"disclosure":""},
{"name":"C Gail Summers, MD","credentials":["Professor, Departments of
Ophthalmology & Visual Neurosciences and Pediatrics\n","University of Minnesota,
Minneapolis, MN"],"disclosure":"Grant/Research/Clinical Trial Support: National Eye
Institute [Albinism]. Consultant/Advisory Board: National Organization for Albinism
and Hypopigmentation [Albinism]."},{"name":"Susan Swetter, MD","credentials":
["Professor of Dermatology\n","Director, Pigmented Lesion & Melanoma
Program\n","Physician Leader, Cancer Care Program in Cutaneous
Oncology\n","Stanford University Medical Center and Cancer Institute/\n","VA Palo
Alto Health Care System"],"disclosure":""},{"name":"Patricia Tai, MB, BS, DABR,
FRCR, FRCPC","credentials":["Clinical Oncologist\n","Clinical
Professor\n","University of Saskatchewan\n","Canada Department of Radiation
Oncology\n","Allan Blair Cancer Center"],"disclosure":""},{"name":"Angela Tewari,
MBBS, BSc, MRCP, PhD","credentials":["King’s College, London"],"disclosure":""},
{"name":"Diane Thiboutot, MD","credentials":["Professor and Vice Chair of
Dermatology Research\n","Penn State University College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Acne (Topical
dapsone, tazarotene)]; Dermira [Acne]; Galderma [Acne (Adapalene, adapalene/benzoyl
peroxide)]; Novartis [Acne]."},{"name":"Danica Tiodorovic, PhD, MD","credentials":
["Associate Professor\n","Clinic of Dermatovenerology, Clinical Center of Nis
Medical Faculty\n","University of Nis, Serbia"],"disclosure":""},{"name":"Andres
Tirado-Sanchez, MD","credentials":["Professor of Dermatology \n","Anahuac
University and Tecnológico de Monterrey"],"disclosure":""},{"name":"Antonella
Tosti, MD","credentials":["Professor of Clinical Dermatology\n","Department of
Dermatology and Cutaneous Surgery, Miller School of Medicine, University of
Miami"],"disclosure":"Great/Research/Clinical Trial Support: Erchonia
[Onychomycosis (Light-emitting diode device)]. Other Financial Interest: Taylor and
Francis book royalties [Dermoscopy]; Springer book royalties [Onychomycosis]."},
{"name":"James R Treat, MD","credentials":["Associate Professor of Pediatrics and
Dermatology\n","Perelman School of Medicine at the University of Pennsylvania;
primary appointment at the Children's Hospital of
Philadelphia"],"disclosure":"Consultant/Advisory Boards: Proctor and Gamble
(Diapers). Speaker's Bureau: Anacor [Atopic dermatitis (Crisaborole)]."},
{"name":"Papapit Tuchinda, MD","credentials":["Assistant Professor, Department of
Dermatology\n","Siriraj Hospital \n","Mahidol University, Bangkok,
Thailand"],"disclosure":""},{"name":"Nathan Uebelhoer, MD","credentials":
["Dermatologist\n","Naval Medical Center, San Diego"],"disclosure":""},
{"name":"Rashmi Unwala, MD","credentials":["Assistant Professor of Medicine -
Department of Dermatology\n","College of Medicine, Mayo Clinic"],"disclosure":""},
{"name":"John Varga, MD","credentials":["John and Nancy Hughes Professor of
Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Neelam Vashi, MD","credentials":["Assistant
Professor of Dermatology\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Allison Vidimos, MD","credentials":["Chairman,
Department of Dermatology\n","Vice Chairman, Dermatology and Plastic Surgery
Institute\n","Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial
Support: Genentech [Registry (Vismodegib)]; Regeneron Pharmaceuticals [Squamous
cell carcinoma (Anti-PD-1 antibody)]."},{"name":"Miikka Vikkula, MD,
PhD","credentials":["Professor of Human Genetics\n","Laboratory of Human Molecular
Genetics, de Duve Institute\n","Catholic University of
Louvain"],"disclosure":"Grant/Research/Clinical Trial Support (Spouse): Pfizer
[Slow-flow vascular anomalies (Rapamycin)]."},{"name":"Ruth Ann Vleugels, MD,
MPH","credentials":["Associate Professor in Dermatology\n","Harvard Medical
School"],"disclosure":""},{"name":"Anna Wald, MD, MPH","credentials":["Professor
of Medicine, Epidemiology, and Laboratory Medicine\n","University of
Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Genocea [Herpes
simplex virus (HSV therapeutic vaccine)]; Vical [Herpes simplex virus (HSV
therapeutic vaccine)]. Consultant/Advisory Boards: AiCuris [Herpes simplex virus
(novel antiviral for HSV)]; GSK [Herpes simplex virus (therapeutic HSV vaccine)];
Merck DSMB [Varicella zoster virus (HSV therapeutic vaccine)]."},{"name":"Karolyn
Wanat, MD","credentials":["Clinical Assistant Professor, Department of
Dermatology\n","University of Iowa"],"disclosure":""},{"name":"Dana S Ward,
MD","credentials":["Associate Professor Emerita of Dermatology\n","University of
Missouri"],"disclosure":""},{"name":"Christine B Warren, MD, MS","credentials":
["Staff\n","Department of Dermatology, Cleveland Clinic"],"disclosure":""},
{"name":"Kalman Watsky, MD","credentials":["Clinical Professor of
Dermatology\n","Yale Medical School"],"disclosure":""},{"name":"Alice J Watson, MD,
MPH","credentials":["Attending Dermatologist\n","Brigham and Women’s
Hospital\n","Instructor in Dermatology\n","Harvard Medical
School"],"disclosure":""},{"name":"Amy C Weintrob, MD","credentials":["Associate
Professor of Medicine\n","The George Washington University and Veterans Affairs
Medical Center"],"disclosure":""},{"name":"Naissan O Wesley, MD","credentials":
["Clinical Professor of Dermatology\n","David Geffen School of Medicine, University
of California Los Angeles"],"disclosure":""},{"name":"William L Weston,
MD","credentials":["Professor Emeritus of Dermatology\n","University of Colorado
Denver School of Medicine"],"disclosure":""},{"name":"David A Wetter,
MD","credentials":["Professor of Dermatology\n","Mayo Clinic, Rochester,
MN"],"disclosure":""},{"name":"Fredrick M Wigley, MD","credentials":["Professor of
Medicine\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring
[Systemic sclerosis (IVIG)]; Corbus [Systemic sclerosis (JBT-101)]; Boehringer
Ingelheim [Interstitial lung disease (Nintedanib)]; Cumberland [Diffuse
scleroderma; pulmonary artery hypertension (Ifetroban)]; Sanofi Aventis
[Scleroderma lung study III (GSK2330811)]. Patent holder: US6847913B2 - Ambulatory
Service Skin Temperature Monitor."},{"name":"Rein Willemze, MD","credentials":
["Professor and Chairman, Department of Dermatology\n","Leiden University Medical
Center"],"disclosure":""},{"name":"Mary Elizabeth Wilson, MD","credentials":
["Clinical Professor of Epidemiology and Biostatistics\n","School of Medicine,
University of California, San Francisco\n","Adjunct Professor of Global Health and
Population\n","Harvard TH Chan School of Public Health"],"disclosure":""},
{"name":"David T Woodley, MD","credentials":["Professor and Chair, Department of
Dermatology\n","The Keck School of Medicine, University of Southern
California"],"disclosure":""},{"name":"Teresa S Wright, MD, FAAD,
FAAP","credentials":["Associate Professor, Dermatology and
Pediatrics\n","University of Tennessee Health Science Center\n","Division Chief,
Pediatric Dermatology\n","LeBonheur Children's Hospital"],"disclosure":""},
{"name":"Eveline Wu, MD","credentials":["Assistant Professor of
Pediatrics\n","University of North Carolina at Chapel Hill"],"disclosure":""},
{"name":"Peggy A Wu, MD","credentials":["Assistant Professor of
Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Kim B Yancey,
MD","credentials":["Professor & Chair, Department of Dermatology \n","University of
Texas Southwestern Medical Center in Dallas"],"disclosure":"Grant/Research/Clinical
Trial Support: NIH [Co-PI on T-32 Award; Participant in a Phase I Multi-
Institutional Clinical Trial]. Consultant/Advisory Board: Ashland Chemical Company,
Inc. [Personal skin care (Products to help manage mild acne and photo
protection)]."},{"name":"James Yiannias, MD","credentials":["Associate
Professor\n","Mayo Clinic College of Medicine"],"disclosure":"Other Financial
Interest: EmpowHER [Allergic contact dermatitis (Mayo Clinic licenses an online
contact allergen avoidance tool)]."},{"name":"Shunsuke Yoshida, MD,
MS","credentials":["Resident\n","UNC Plastic & Reconstructive
Surgery"],"disclosure":""},{"name":"Gil Yosipovitch, MD","credentials":["Department
of Dermatology\n","University of Miami, Miller School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: LEO Foundation
[Itch in eczema and psoriasis]; Trevi Therapeutics [Itch (Nalbuphine)]; Menlo
Therapeutics [Itch (Neurokinin 1 inhibitor)]; Sun Pharmaceutical Industries [Itch
(Crotamiton)]. Consultant/Advisory Boards: Trevi Therapeutics [Itch (Nalbuphine)];
Menlo Therapeutics [Itch (Neurokinin 1 inhibitor)]; Eli Lilly [Itch (Ixekizumab)];
Pfizer [Itch (Tofacitinib, crisaborole)]; Regeneron [Itch (Interleukin 4 and 13)];
Sanofi [Itch (Interleukin 4 and 13)]; Allergen [Itch (OnabotulinumtoxinA)]; OPKO
Health [Itch (Neurokinin 1 inhibitor)]; Tioga Pharmaceuticals [Itch (Kappa-opioid
receptor)]; Novartis [Itch (H4 antagonist)]; Galderma [Atopic dermatitis and
pruritus (Nemolizumab)]; Sienna Pharmaceuticals [Pruritus (Pegcantratinib, SNA-
125)]; Vanda Pharmaceuticals [Atopic dermatitis (Kappa opioid receptor
antagonist)]."},{"name":"Antony R Young, PhD","credentials":["Professor\n","St
John's Institute of Dermatology, Faculty of Life Sciences and Medicine\n","King's
College London, London, United Kingdom"],"disclosure":"Grant/Research/Clinical
Trial Support: BASF [Sunscreen photoprotection (Sunscreen in development)].
Speaker's Bureau: Pierre Fabre [Sunscreen photoprotection (Over-the-counter
sunscreen)]."},{"name":"Andrea Zaenglein, MD","credentials":["Professor of
Dermatology and Pediatrics\n","Penn State/Milton S. Hershey Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ranbaxy Laboratories;
Sun Pharmaceuticals Industries [Acne (Isotretinoin)]; Allergan [Acne (Dapsone)];
Dermavant Sciences [Atopic dermatitis (Investigational)]. Speaker's Bureau: Valeant
[Atopic dermatitis (Pimecrolimus)]. Consultant/Advisory Boards: Cassiopea [Acne
(Investigational)]; Dr Reddy's [Acne (Isotretinoin)]."},{"name":"Iris Zalaudek,
MD","credentials":["Associate Professor, Division of Dermatology and
Venerology\n","Medical University of Graz"],"disclosure":""},{"name":"Mirjana
Ziemer, MD, PhD","credentials":["Senior Physician, Dermatohistopathologist -
Department of Dermatology, Venereology, and Allergology\n","University Hospital
Leipzig, Leipzig, Germany"],"disclosure":""},{"name":"Matthew J Zirwas,
MD","credentials":["Associate Clinical Professor\n","The Ohio State
University"],"disclosure":"Grant/Research/Clinical Trial Support: LEO Pharma
[Atopic dermatitis (Tralokinumab)]; Janssen Pharmaceuticals [Psoriasis
(Guselkumab)]; Foamix Pharmaceuticals [Rosacea, acne (Topical minocycline)]; DS
Biopharma [Atopic dermatitis (DS107)]; UCB [Psoriasis (Bimekizumab)]; Incyte
[Atopic dermatitis (Ruxolitinib)]. Speaker's Bureau: Regeneron Pharmaceuticals;
Sanofi [Atopic dermatitis (Dupilumab); Genentech; Novartis [Chronic urticaria
(Omalizumab)]. Consultant/Advisory Boards: Valeant Pharmaceuticals International;
Medimetriks Pharmaceuticals; Promius Pharma; Exeltis; Smart Practice; Anacor
Pharmaceuticals; Sun Products [Nummular eczema (Cleansers, moisturizers, healing
ointments, sunscreen, hydrocortisone butyrate, neomycin-fluocinolone, betamethasone
valerate, patch testing materials, crisaborole, laundry detergent, fabric
softeners)]; Genentech [Urticarial dermatitis (Omalizumab)]."},{"name":"John J
Zone, MD","credentials":["Section Editor — Bullous Disease\n","Professor and
Chairman, Department of Dermatology\n","University of Utah"],"disclosure":""},
{"name":"Francesco Zulian, MD","credentials":["Chief, Pediatric Rheumatology
Unit\n","University of Padua, Italy"],"disclosure":""},{"name":"Bruce Zuraw,
MD","credentials":["Professor of Medicine\n","University of California San
Diego"],"disclosure":"Consultant/Advisory Boards: Shire [Hereditary angioedema
(Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-
nf)]; BioCryst [Hereditary angioedema]; Novartis [Allergy]; Genentech [Allergy].
Consultant/Advisory Boards (Spouse): Shire [Hereditary angioedema (Icatibant,
ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-nf)]."},
{"name":"Fiona Zwald, MD, MRCPI","credentials":["Assistant Professor of
Dermatology\n","Department of Dermatology - Emory University"],"disclosure":""},
{"name":"Jeffrey Zwerner, MD","credentials":["Assistant Professor of
Dermatology\n","Vanderbilt University"],"disclosure":""}]},{"name":"Peer
Reviewers","contributors":[{"name":"David M Allen, MD, FAAD","credentials":
["Assistant Clinical Professor (Adjunct)\n","University of Utah Department of
Dermatology\n","Director\n","Intermountain Skin, Cancer and Esthetics
Center"],"disclosure":""},{"name":"Jeremy Bordeaux, MD, MPH","credentials":
["Assistant Professor of Dermatology\n","Case Western Reserve
University"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":
["Assistant Professor of Dermatology\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Sylvia Brice, MD","credentials":["Associate
Professor of Dermatology\n","University of Colorado Denver, School of
Medicine"],"disclosure":""},{"name":"Jeffrey Callen, MD, FACP, FAAD","credentials":
["Editor-in-Chief — Dermatology\n","Section Editor — Skin and Systemic
Disease\n","Professor of Medicine\n","University of Louisville School of
Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in
patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and
Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus
erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations
for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson
and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS;
Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept,
adalimumab, tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen;
Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie;
Procter and Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions
(Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]."},{"name":"Ser
Ling Chua, MBBS, FRCP, PhD","credentials":["Consultant Dermatologist\n","Queen
Elizabeth Hospital, University Hospitals Birmingham NHS Foundation
Trust"],"disclosure":"Speaker's Bureau: AbbVie [Hidradenitis suppurativa
(Adalimumab)]. Consultant/Advisory Boards: Abbvie [Hidradenitis suppurativa
(Adalimumab)]."},{"name":"Christina Lee Chung, MD","credentials":["Associate
Professor\n","Drexel University"],"disclosure":""},{"name":"Oscar Colegio, MD,
PhD","credentials":["Associate Professor of Dermatology, Pathology, and
Surgery\n","Yale University School of Medicine"],"disclosure":""},{"name":"Cory A
Dunnick, MD","credentials":["Assistant Professor of Dermatology\n","University of
Colorado Denver, School of Medicine"],"disclosure":""},{"name":"Jan Peter Dutz,
MD","credentials":["Professor - Department of Dermatology and Skin
Science\n","University of British Columbia"],"disclosure":""},{"name":"Daniel B
Eisen, MD","credentials":["Professor of Clinical Dermatology\n","University of
California Davis, Department of Dermatology"],"disclosure":""},{"name":"Anthony F
Fransway, MD","credentials":["Associates in Dermatology MD's, LLC\n","Fort Myers,
FL"],"disclosure":""},{"name":"Ilona J Frieden, MD","credentials":["Professor of
Dermatology and Pediatrics\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards: Pierre Fabre Dermatology
[Infantile hemangiomas (Propranolol liquid formulation)]."},{"name":"Anthony
Gaspari, MD","credentials":["Chief, Section of Dermatology\n","Lancaster General
Hospital"],"disclosure":""},{"name":"Barbara A Gilchrest, MD","credentials":
["Professor-in-Residence\n","Department of Dermatology\n","Harvard Medical
School"],"disclosure":""},{"name":"Lynne J Goldberg, MD","credentials":["Professor
of Dermatology and Pathology and Laboratory Medicine\n","Boston University School
of Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Hair growth];
Living Proof."},{"name":"Roderick J Hay, DM","credentials":["Emeritus Professor of
Cutaneous Infection\n","King's College London"],"disclosure":""},{"name":"Molly A
Hinshaw, MD","credentials":["Clinical Associate Professor of
Dermatology\n","UWSMPH, Madison WI\n","Clinical Assistant Professor of
Der"],"disclosure":"Patent Holder: Accure Medical, LLC [onychomycosis]. Equity
Ownership/Stock Options: Accure Medical, LLC [onychomycosis]."},{"name":"Daniel
Hohl, MD","credentials":["Full Professor\n","Lausanne University
Hospital"],"disclosure":""},{"name":"J Clark Huff, MD","credentials":["Professor of
Dermatology\n","University of Colorado School of Medicine"],"disclosure":""},
{"name":"Joseph Jorizzo, MD","credentials":["Professor and Former (Founding)
Chair\n","Wake Forest University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Psoriasis]."},
{"name":"Brandi M Kenner-Bell, MD, FAAD, FAAP","credentials":["Assistant Professor
of Pediatrics and Dermatology\n","Northwestern University's Feinberg School of
Medicine\n","Ann & Robert H. Lurie Children's Hospital of
Chicago"],"disclosure":""},{"name":"Caroline C Kim, MD","credentials":["Director,
Pigmented Lesion Clinic\n","Associate Director, Cutaneous Oncology
Program\n","Department of Dermatology\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Hoffmann-La Roche
[Melanoma (Vemurafenib)]; MetaOptima [Skin imaging (Smartphone attachment for
dermoscopy)]. Consultant/Advisory Boards: DAMAE Medical [Skin imaging]."},
{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL
(mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL
(brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix
[CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-
12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory
Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin
diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)],
Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL
(Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)],
Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)],
Medivir."},{"name":"Andrew C Krakowski, MD","credentials":["Assistant Clinical
Professor\n","University of California, San Diego, and Rady Children's Hospital,
San Diego"],"disclosure":""},{"name":"Daniela Kroshinsky, MD","credentials":
["Assistant Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},
{"name":"Drew Joseph Benedict Kurtzman, MD","credentials":["Assistant Professor of
Medicine (Dermatology)\n","Director, Connective Tissue Disease Clinic\n","The
University of Arizona"],"disclosure":""},{"name":"Leah Lalor, MD","credentials":
["Pediatric Dermatology Fellow\n","University of California, San Francisco School
of Medicine"],"disclosure":""},{"name":"Ronald Laxer, MD, FRCPC","credentials":
["Professor of Pediatrics\n","University of
Toronto"],"disclosure":"Grant/Research/Clinical Trial Support: Scleroderma Society
of Ontario [Morphea (Studies)]."},{"name":"Ashfaq A Marghoob, MD","credentials":
["Attending Physician\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":""},{"name":"David J Margolis, MD, PhD","credentials":
["Associate Professor of Dermatology\n","University of
Pennsylvania"],"disclosure":""},{"name":"Catalina Matiz, MD","credentials":
["Assistant Professor of Dermatology\n","Division of Pediatric & Adolescent
Dermatology, University of California San Diego"],"disclosure":""},{"name":"Beth N
McLellan, MD","credentials":["Assistant Professor\n","Albert Einstein College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Ferndale Pharma Group
[Radiation dermatitis (Polypodium leucotomos extract dietary supplement)]."},
{"name":"Jemima Mellerio, BSc, MD, FRCP","credentials":["Consultant Dermatologist &
Honorary Senior Lecturer\n","St. John's Institute of
Dermatology"],"disclosure":"Grant/Research/Clinical Trial Support: Castle Creek
Pharmaceuticals [Epidermolysis bullosa simplex (Diacerein)]. Consultant/Advisory
Boards: ProQR Therapeutics [Epidermolysis bullosa (Investigational drug)]; Thornton
& Ross [Eczema (Emollients)]."},{"name":"Misha D Miller, MD","credentials":
["Assistant Professor\n","Department of Dermatology\n","Department of Obstetrics
and Gynecology\n","University of Colorado"],"disclosure":""},{"name":"Eliot Mostow,
MD","credentials":["Professor and Chair, Dermatology Section\n","Northeastern Ohio
University College of Medicine"],"disclosure":"Consultant/Advisory Boards: Vivacare
[Patient information on web and app platforms]. Employment: Elsevier [Dermatology
Assistant Editor, practiceupdate.com]."},{"name":"Jenny E Murase,
MD","credentials":["Assistant Clinical Professor\n","Department of Dermatology,
UCSF"],"disclosure":""},{"name":"Paul T Nghiem, MD, PhD","credentials":["Professor
& Head\n","University of Washington Dermatology\n","George F. Odland Chair in
Dermatology"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers
Squibb [Merkel cell carcinoma (Nivolumab)]; EMD Serono [Merkel cell carcinoma
(Avelumab)]. Consultant/Advisory Boards: EMD Serono [Merkel cell carcinoma
(Avelumab)]."},{"name":"Cindy Owen, MD","credentials":["Assistant Professor of
Medicine\n","University of Louisville"],"disclosure":""},{"name":"Bianca Maria
Piraccini, MD, PhD","credentials":["Associate Professor of
Dermatology\n","University of Bologna, Italy"],"disclosure":""},{"name":"Maureen B
Poh-Fitzpatrick, MD","credentials":["Professor Emerita and Special
Lecturer\n","Department of Dermatology, Columbia University College of
Ph"],"disclosure":""},{"name":"Ted Rosen, MD","credentials":["Section Editor —
Infections and Infestations\n","Professor, Department of Dermatology\n","Baylor
College of Medicine"],"disclosure":"Consultant/Advisory Boards: Cipher [Herpes
labialis (Acyclovir buccal tablet)]; Medimetriks [Impetigo (Ozenoxacin
topical)]."},{"name":"Noah Scheinfeld, MD","credentials":["Assistant Clinical
Professor of Dermatology\n","Weill Cornell Medical
College"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hidradenitis
suppurativa (Adalimumab)]. Consultant/Advisory Boards: AbbVie [Hidradenitis
suppurativa (Adalimumab)]. Speaker’s Bureau: AbbVie [Hidradenitis suppurativa
(Adalimumab)]."},{"name":"Robert Sidbury, MD, MPH","credentials":["Professor -
Department of Pediatrics\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm
[Epidermolysis bullosa (Investigational cream)]; Sanofi/Regeneron [Atopic
dermatitis (Investigational biologic)]. Consultant/Advisory Boards: Roche [Acne
(Accutane - no longer made)]; Pfizer [Atopic dermatitis (Crisaborole)]."},
{"name":"Steven Brett Sloan, MD","credentials":["Associate Professor of
Dermatology\n","University of Connecticut"],"disclosure":"Consultant/Advisory
Boards: WebMD [slide show advisor]. Employment: Journal of the American Academy of
Dermatology."},{"name":"Robert S Stern, MD","credentials":["Section Editor —
Nonmelanoma Skin Cancer\n","Professor of Dermatology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Advance
skin cancer (Checkpoint inhibitors)]; Plexxikon [Advance skin cancer (Various
drugs)]; Hydra [Advance skin cancer (Various drugs)]. Other Financial Interest:
Mylan [Skin reactions (Expert in product liability case concerning phenytoin skin
reaction)]; United State Department of Justice [Malpractice defense]."},
{"name":"Susan Swetter, MD","credentials":["Professor of Dermatology\n","Director,
Pigmented Lesion & Melanoma Program\n","Physician Leader, Cancer Care Program in
Cutaneous Oncology\n","Stanford University Medical Center and Cancer
Institute/\n","VA Palo Alto Health Care System"],"disclosure":""},{"name":"Brian L
Swick, MD","credentials":["Clinical Associate Professor\n","University of Iowa
Departments of Dermatology and Pathology\n","Iowa City VAMC"],"disclosure":""},
{"name":"Kenneth J Tomecki, MD","credentials":["Department of
Dermatology\n","Cleveland Clinic"],"disclosure":""},{"name":"Antonio Torrelo,
MD","credentials":["Head, Department of Dermatology\n","Hospital Infantil
Universitario Niño Jesus"],"disclosure":""},{"name":"Jashin J Wu, MD,
FAAD","credentials":["Director of Dermatology Research\n","Kaiser Permanente Los
Angeles Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support:
AbbVie [Psoriasis (Adalimumab)]; Amgen [Psoriasis (Etanercept)]; Eli Lilly
[Psoriasis] (ixekizumab); Janssen [Psoriasis (Infliximab, ustekinumab,
guselkumab)]; Novartis [Psoriasis (Secukinumab)]; Regeneron [atopic dermatitis
(dupilumab)]."},{"name":"Antony R Young, PhD","credentials":["Professor\n","St
John's Institute of Dermatology, Faculty of Life Sciences and Medicine\n","King's
College London, London, United Kingdom"],"disclosure":"Grant/Research/Clinical
Trial Support: BASF [Sunscreen photoprotection (Sunscreen in development)].
Speaker's Bureau: Pierre Fabre [Sunscreen photoprotection (Over-the-counter
sunscreen)]."},{"name":"Andrea Zaenglein, MD","credentials":["Professor of
Dermatology and Pediatrics\n","Penn State/Milton S. Hershey Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ranbaxy Laboratories;
Sun Pharmaceuticals Industries [Acne (Isotretinoin)]; Allergan [Acne (Dapsone)];
Dermavant Sciences [Atopic dermatitis (Investigational)]. Speaker's Bureau: Valeant
[Atopic dermatitis (Pimecrolimus)]. Consultant/Advisory Boards: Cassiopea [Acne
(Investigational)]; Dr Reddy's [Acne (Isotretinoin)]."}]}]}